Director and Gene Therapy Program Coordinator

ORCID ID orcid.org/0000-0002-0850-8445

ResearcherID N-5883-2014

Scopus Author ID 56082113500 

H-INDEX (Google Scholar): 63

i10-INDEX: 123

Total number of citations (Google Scholar): 18.282

DATE OF BIRTH: May 17, 1956

CURRENT POSITION

2004-: Full Professor of Biochemistry, University of Modena and Reggio Emilia, Modena, Italy

2008-: Director, Centre for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia, Modena, Italy

2008-: Scientific Director and Founder, Holostem Terapie Avanzate S.r.l., spin-off of the University of Modena and Reggio Emilia, Modena, Italy

2010-: Director, Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

2012-: QP, Holostem Terapie Avanzate, Modena, Italy

2019-: Coordinator, PhD Program in Molecular and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

EDUCATION

1984 – Specialty in Endocrinology, summa cum laude, University of Rome Medical School. 

1980 – M.D., summa cum laude, University of Catania Medical School.

TRAINING

1985: Visiting scientist at the Department of Physiology and Biophysics, Harvard Medical School (HMS), Boston, MA, USA 

1982-1985: Fogarty Fellow, Section on Biochemistry of Cell Regulation, Laboratory of Biochemical Pharmacology, National Institutes of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK), National Institutes of Health (NIH), Bethesda, MD, USA

PREVIOUS APPOINTMENTS

2002-2007: Scientific Director, Veneto Eye Bank Foundation, Venice, Italy

1996-2002: Head, Laboratory of Tissue Engineering, Istituto Dermopatico dell’Immacolata (IDI), Roma, Italy

1992-1995: Deputy Head, Laboratory of Cell Differentiation, National Institute for Cancer Research, Genova, Italy

1986-1992: Senior Investigator, Laboratory of Cell Differentiation, National Institute for Cancer Research, Genova, Italy

MISCELLANEA

Michele De Luca is member of several scientific societies, several national and international commitees and founding member of the International Ocular Surface Society (IOSS) and of the Stem Cell Research Italy (SCR Italy). Honorary member of’Associazione degli allievi del Collegio Ghisleri di Pavia and ordinary member of of EMBO (European Molecular Biology Organization), Accademia Nazionale dei Lincei and Accademia Nazionale di Scienze, Lettere e Arti di Modena.

Michele De Luca is author of 140 peer reviewed international publications and book chapters and has been invited speaker in over 200 international meetings and has held 140 seminars and courses worldwide.

Michele De Luca, additional to his academic and scientific activity, has an extensive experience of outreach and communication to the public, including direct engagement with schools and adult audiences, newspaper, radio and TV and has a key role in Italian debate on stem cells and regenerative medicine (http://www.cmr.unimore.it/rassegna_stampa.html). 

Since 2013, Michele De Luca has been co-President of the Luca Coscioni Association for the freedom of science.


SUMMARY AND ESSENCE OF SCIENTIFIC ACTIVITY

Michele De Luca has dedicated most of his scientific activities to translational medicine and is recognised as leading scientist in human squamous epithelial stem cell biology aimed at the development of epithelial stem cell-mediated cell therapy and gene therapy (Stem Cell Reports. 2018; Nat. Cell. Biol. 2019; Cold Spring Harb Perspect Biol. 2020).

Following on early work on the use of human epidermal stem cell cultures in life-saving treatment of massive full-thickness burns and in repigmentation of stable vitiligo and piebaldism by keratinocyte/melanocyte co-colture (reviewed in Regen. Med. 2006), Michele De Luca established human urethral stem cell culture aimed at urethral regeneration in posterior hypospadias (N. Engl. J. Med. 1990; J. Urol. 1993).

De Luca and his historic collaborator Graziella Pellegrini developed human limbal stem cell culture (J. Cell Biol. 1999) for corneal regeneration in patients with severe limbal stem cell deficiency (Lancet 1997; Transplantation 2001; N. Engl. J. Med 2010; Regen. Med. 2013; Stem Cells Transl Med. 2018). This treatment leads to recovery of normal vision and is now used worldwide. In February 2015 such cultures were formally approved as an Advanced Therapy Medicinal Product by EMA, which registered them under the name of Holoclar. Holoclar is the first stem cell-based therapy approved in Europe and EMA has indicated it amongst the most relevant achievements in the field in the last 20 years.

Michele De Luca has characterised molecular mechanisms regulating long term proliferative potential, clonal evolution and self-renewal of epithelial stem cells. In particular, he shed light on the role of p63 (different isoforms) and c/EBPδ in regulating the proliferative potential and the self-renewal of human corneal stem cells, respectively (PNAS 2001, 2005; J. Cell Biol. 2007). Notably, their work demonstrated that the clinical success of limbal stem cultures is dependent on a discrete number of stem cells identified as holoclones expressing the ΔNα isoform of p63 (N. Engl. J. Med.  2010, TMM 2011, Regen. Med. 2013).

Michele De Luca is also pioneering ex-vivo epithelial stem cell-mediated gene therapy for genetic skin diseases. He coordinated the first successful clinical trial to treat junctional epidermolysis bullosa (JEB) (Nat. Med. 2006; Stem Cell Rep. 2014; J. Invest. Dermatol, 2017; Nature, 2017; Cell Rep. 2019; ; Cold Spring Harb Perspect Biol. 2020; N. Engl. J. Med. 2021) and is coordinating clinical trials for other forms of EB.

JEB is a severe, often lethal genetic disease caused by mutations in genes encoding the basement membrane component laminin-332. Surviving JEB patients develop chronic skin and mucosa wounds, which impair their quality of life and lead to skin cancer. De Luca has recently reported life-saving regeneration of the entire, fully functional, epidermis on a 7-year-old child suffering from a devastating, life-threatening form of JEB (Nature, 2017). Using integrations as clonal genetic marks, he has shown that the vast majority of epidermal TA progenitors are progressively lost within a few months after grafting and the regenerated epidermis is indeed sustained only by a limited number of long-lasting, self-renewing stem cells. This notion fosters a model where specific stem cells persist during the lifetime of the human and contribute to both renewal and repair by giving rise to pools of progenitors that persist for various periods of time, replenish differentiated cells and make short-term contribution to wound healing (Nature, 2017). Based on this notion and on the corneal data (N. Engl. J. Med 2010) De Luca thus established that the essential feature of any cultured epithelial grafts is the presence (and preservation) of an adequate number of holoclone-forming cells and provided a blueprint that can be applied to other stem cell-mediated ex vivo cell and gene therapies.

During his studies on JEB, De Luca has shown that nuclear YAP and its downstream effector FOXM1 are key determinants of human holoclones. YAP/FOXM1 interplay with p63 is essential for sustaining epithelial stem cell self-renewal and proliferative/regenerative capacity and their dysregulation underpin epidermal stem cell depletion usually observed in LAMB3-dependent JEB (Cell Rep. 2019, Nat Comm 2021).

Michele De Luca is internationally recognised for his experience in stem cell therapy and contributed to two reports by the International Society for Stem Cell Research, dealing with new guidelines for responsible translational stem cells research (Cell Stem Cell 2008, 2009).

During the past 30 years, Michele De Luca and Graziella Pellegrini, in collaboration with several clinicians, have treated:

• Approximately 400 patients with massive skin burns (life-saving)

• Over 400 patients with massive ocular burns (restoration of vision)

• Approximately 100 patients with stable vitiligo and piebaldism

• 170 patients with oral mucosa defects

• Approximately 10 patients with posterior hypospadias

• 3 patients with JEB (in Italy, Austria and Germany)

current PhaseI/II clinical trials of ex vivo gene therapy of Epidermolysis Bullosa (24 patients enrolled in Europe)

by means of cultured and highly characterized epithelial stem cells.


NATIONAL AND INTERNATIONAL AWARDS AND RECOGNITIONS

AWARDS
  1. 2020 – Rotary Club Toscana, Paul Harrys Fellow
  2. 2020 – Fondation Louis-Jeantet, Louis-Jeantet Prize (co-awarded with Graziella Pellegrini)
  3. 2019 – Rotary Club Casalmaggiore, Paul Harrys Fellow
  4. 2019 – Regione Emilia-Romagna, Menzione speciale “Innovazione, ricerca ed eccellenze in Emilia-Romagna
  5. 2019 – New York Academy of Science & Takeda Pharmaceuticals, “Innovator in Science Award 2019”
  6. 2018 – International Prize “Lombardia è ricerca” (co-awarded with Tobias Hirsch and Graziella Pellegrini)
  7. 2018 – Royan Institute (Teheran), Kazemi Award for Research Excellence in Bio-Medicine
  8. 2018 – EURORDIS, Black Pearl Award – Scientific Award (co-awarded with Tobias Hirsch)
  9. 2018 – ISSCR, Award for innovation (co-awarded with Graziella Pellegrini)
  10. 2017 – The Niche (Knoepfler Lab Blog Stem Cell Blog), Stem Cell Person of the Year Award
  11. 2016 – Prix Galien Netherlands 2016 for Holoclar
  12. 2016 – Prix Galien United Kingdom 2016 for Holoclar
  13. 2016 – UNICEF, Premio Ragno d’Oro
  14. 2015 – “Menzione speciale all’innovazione” for Holoclar, Premio Galeno Italia
  15. 2015 – Premio Luigi Coppola – Città di Gallipoli
  16. 2015 – Comune di Modena, Premio Città di Modena – “Bonissima” awarded by Centre for Regenerative Medicine “Stefano Ferrari”
  17. 2015 – Comune di Modena, Premio Città di Modena – “Bonissima” awarded by Holostem Terapie Avanzate
  18. 2015 – MIT Technology Review Italia, “Smart & Disruptive Companies 2015” Award to Holostem Terapie Avanzate
  19. 2014 – ISSCR, Public Service Award (co-awarded with Paolo Bianco and Elena Cattaneo)
  20. 2014 – Comune di Milano, Premio Ambrosoli
  21. 2014 – Comune di Padova, Menzione Speciale della giuria scientifica del Premio Galileo per la Divulgazione Scientifica (co-awarded with Paolo Bianco, Elena Cattaneo and Gilberto Corbellini)
  22. 2008 – Debra Italia Onlus, Premio Farfalla d’argento
RECOGNITIONS
  1. Life member of the New York Academy of Science
  2. Member of Accademia Nazionale dei Lincei
  3. Member of the European Molecular Biology Oragnization (EMBO)
  4. Honorary Member of Associazione degli allievi del Collegio Ghisleri di Pavia
  5. Member of Accademia nazionale di Scienze, Lettere e Arti di Modena
  6. Private meeting with the Italian President Sergio Mattarella, Rome, 16 May 2018
  7. Honorary member of the patients’ association Debra Südtirol Alto Adige

SCIENTIFIC SOCIETIES AND COMMITMENTS

  1. 2020-: NSC-Reconstruct, Member of the Scientific and Ethical Advisory Board
  2. 2019-: SkinTERM, Member of the Advisory Board
  3. 2019-: Osservatorio Terapie Avanzate, Member of Scientific Advisory Board
  4. 2019-: Charity “Le ali di Camilla”, Founding member
  5. 2019-: New York Academy of Science, Life member
  6. 2018-: Novo Nordisk Foundation Center for Stem Cell biology (DANSTEM) , Member of Scientific Advisory Board
  7. 2018-: Accademia dei Lincei, Fellow
  8. 2018-: EMBO Member
  9. 2017-: National Institut for Health Research (NIHR) Great Ormond Street Hospital Biomedical Research Centre (GOSH BRC), Member of the External Advisory Board
  10. 2015-: Emilia-Romagna Clust-ER Health, Chairman of the value chain Regenerative and Reparative Medicine
  11. 2014-: Accademia Nazionale di Scienze, Lettere e Arti di Modena, Fellow
  12. 2012-: REVIVE, Member of the Scientific Advisory Board
  13. 2008: ISSCR International Committee on Clinical Translation, Member
  14. 2008-: Skin Diseases Research Core Center, University of Colorado Denver, Medical School, Member of External Advisory Board
  15. 2008-: Holostem Terapie Avanzate S.r.l., Modena, Italy, Founder and member of the Board of Directors
  16. 2008-:  Stem Cell Research Italy, Founder and member of the Techinical-Scientific Committe
  17. 2007: International Society for Stem Cell Research (ISSCR), Member of the Task Force on Clinical Translation of Stem Cells
  18. 2007-: International Journal of Molecular Medicine, Member of the Editorial Academy
  19. 2005-2007:  Istituto Superiore di Sanità-Centro Nazionale Trapianti, Member of Working Group on Engineered Cells
  20. 2004-2007: Regional Laboratory of Stem Cells (Cell Factory), Venice, Italy, Member of the Regional Technical Scientific Committee
  21. 2004-2007: National Epidermolysis Bullosa Network, Germany, Member of the International Advisory Board
  22. 2004-: ISSCR Member
  23. 2003: ESGCT (European Society of Gene & Cell Therapy), Member of the Scientific Committee
  24. 2002-: American Association for the Advancement of Science, Member
  25. 2002-2004: “TEGO Science”, Seoul, South Korea, Member of the Scientific Council
  26. 2001-2008: Member of the National Commission of Health Ministry for Stem Cells
  27. 2001-2003: ISOTIS, Tissue Engineers”, Amsterdam, The Netherlands, Member of the Scientific Council
  28. 2001-2002: “Banca degli Occhi dell’Ente Ospedaliero S. Giovanni-Addolorata”, Rome, Italy, Member of the Scientific Committee
  29. 2000-: International Ocular Surface Society, Funding member
  30. 2000-: Reviewer of various International Scientific Magazines including Cell, Nature, N. Eng. J. Med., J. Cell Biol., Proc. Natl. Acad. Sci. USA.
  31. 1999-: J-TEC, Gamagori, Japan, Member of the Scientific Council
  32. 1999-2002:  Italian Society for Cell Biology and Differentiation, Member of the Board
  33. 1998-1999: Member of the Group of Istituto Superiore di Sanità for the Guidelines of Cellular and Genic Therapy
  34. 1996-: European Society for Dermatological Research, Member

PUBLICATIONS

SCIENTIFIC PAPER
  1. Kueckelhaus M, Rothoeft T, De Rosa L, Yeni B, Ohmann T, Maier C, Eitner L, Metze D, Losi L, Secone Seconetti A, De Luca M, Hirsch T. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa – 5-Year Outcomes. N Engl J Med. 2021 Dec 9;385(24):2264-2270. doi: 10.1056/NEJMoa2108544.PMID: 34881838
  2. De Rosa L, Enzo E, Zardi G, Bodemer C, Magnoni C, Schneider H, De Luca M. Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa. Front Genet. 2021 Sep 1;12:705019. doi: 10.3389/fgene.2021.705019. eCollection 2021.
  3. Enzo E, Secone Seconetti A, Forcato M, Tenedini E, Polito MP, Sala I, Carulli S, Contin R, Peano C, Tagliafico E, Bicciato S, Bondanza S, De Luca M. Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells. Nat Commun. 2021 May 4;12(1):2505. doi: 10.1038/s41467-021-22779-9.
  4. Wagner RN, Piñón Hofbauer J, Wally V, Kofler B, Schmuth M, De Rosa L, De Luca M, Bauer JW. Epigenetic and metabolic regulation of epidermal homeostasis, Exp Dermatol. 2021 Feb 18. doi: 10.1111/exd.14305. Online ahead of print.
  5. De Rosa L, Latella MC, Secone Seconetti A, Cattelani C, Bauer JW, Bondanza S, De Luca M. Toward Combined Cell and Gene Therapy for Genodermatoses. Cold Spring Harb Perspect Biol. 2020 May 1;12(5):a035667. doi: 10.1101/cshperspect.a035667. Epub 2019 Oct 25.
  6. Bassi R, Bucci EM, Calogero R, Carninci P, Ciliberto G, Conte P, De Luca M, Corbellini G, Giordano A, Marchionni L, Massaro Giordano G, Parini A, Sbardella G. Look for methods, not conclusions. Cell Death and Disease 2019 Dec 1;10:931 doi: 10.1038/s41419-019-2179-8
  7. De Luca M, Aiuti A, Cossu G, Parmar M, Pellegrini G, Robey PG. Advances in stem cell research and therapeutic development. Nat Cell Biol. 2019 Jul;21(7):801-811. doi: 10.1038/s41556-019-0344-z. Epub 2019 Jun 17.
  8. De Rosa L, Secone Seconetti A, De Santis G, Pellacani G, Hirsch T, Rothoeft T, Teig N, Pellegrini G, Bauer JW, De Luca M. Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa. Cell Rep. 2019 May 14;27(7):2036-2049.e6. doi: 10.1016/j.celrep.2019.04.055.
  9. De Pace B, Fiorentini C, Ciardo S1 Chester J, Kaleci S, Veltri T, De Luca M, Pellacani G. Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e120-e123. doi: 10.1111/jdv.15304. Epub 2018 Nov 15.
  10. Pellegrini G, De Luca M. Living with Keratinocytes. Stem Cell Reports. 2018 Nov 13;11(5):1026-1033. doi: 10.1016/j.stemcr.2018.10.005.
  11. Lincoln V, Cogan J, Hou Y, Hirsch M, Hao M, Alexeev V, De Luca M, De Rosa L, Bauer JW, Woodley DT, Chen M. Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa. Proc Natl Acad Sci U S A. 2018  Jul 10;115(28):E6536-E6545. doi: 10.1073/pnas.1803154115. Epub 2018 Jun 26.
  12. De Rosa L, Koller U, Bauer JW, De Luca M, Reichelt J. Advances on potential therapeutic options for epidermolysis bullosa. Expert Opinion on Orphan Drugs 2018 Apr 17;, vol. 6, p. 283-293, ISSN: 2167-8707, doi: 10.1080/21678707.2018.1463216
  13. Pellegrini G, Ardigò D, Milazzo G, Iotti G, Guatelli P, Pelosi D, De Luca M. Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union. Stem Cells Transl Med. 2018 Jan;7(1):146-154. doi: 10.1002/sctm.17-0003. Epub 2017 Dec 27.
  14. Hirsch T, Rothoeft T, Teig N, Bauer JW, Pellegrini G, De Rosa L, Scaglione D, Reichelt J, Klausegger A, Kneisz D, Romano O, Secone Seconetti A, Contin R, Enzo E, Jurman I, Carulli S, Jacobsen F, Luecke T, Lehnhardt M, Fischer M, Kueckelhaus M, Quaglino D, Morgante M, Bicciato S, Bondanza S, De Luca M. Regeneration of the entire human epidermis using transgenic stem cells. Nature. 2017 Nov 16;551(7680):327-332. doi: 10.1038/nature24487. Epub 2017 Nov 8.
  15. Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ. Marketing of unproven stem cell-based interventions: A call to action. Sci Transl Med. 2017 Jul 5;9(397). pii: eaag0426. doi: 10.1126/scitranslmed.aag0426
  16. Latella MC, Cocchiarella F, De Rosa L, Turchiano G, Gonçalves MA, Larcher F, De Luca M, Recchia A. Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. J Invest Dermatol. 2017 Apr; 137(4):836-44. Epub 2016 Dec 24
  17. Bauer JW, Koller J, Murauer EM, De Rosa L, Enzo E, Carulli S, Bondanza S, Recchia A, Muss W, Diem A, Mayr E, Schlager P, Gratz IK, Pellegrini G, De Luca M. Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells. J Invest Dermatol. 2017 Mar;137(3):778-781. doi: 10.1016/j.jid.2016.10.038. Epub 2016 Nov 10
  18. Milazzo G, Ardigò D, Toschi M, Matuska S, Rama P, De Luca M, Pellegrini G. Holoclar: first of its kind in more ways than one. Cell Gene Therapy Insights 2016 July 6;2(2):183-197. doi:10.18609/cgti.2016.023
  19. Cossu G, Buccione R, De Luca M. A discussion on cell therapy in Manchester. Stem Cell Res. 2016 May;16(3):614-6. doi: 10.1016/j.scr.2016.03.005. Epub 2016 Mar 21.
  20. Corradini F, Zattoni M, Barbagli G, Bianchi G, Giovanardi M, Serafini C, Genna V, Ribbene A, Balò S, Fidanza F, Lazzeri M, De Luca M, Pellegrini G. Comparative Assessment Of Cultures From Oral And Urethral Stem Cells For Urethral Regeneration. Curr Stem Cell Res Ther. 2016;11(8):643-651. doi: 10.2174/1574888×10666150902094644.
  21. Murauer EM, Koller U, Pellegrini G, De Luca M, Bauer JW, Advances in Gene/Cell Therapy in Epidermolysis Bullosa, Keio J Med. 2015 Jun 25;64(2):21-5. doi: 10.2302/kjm.2014-0013-RE. Epub 2015 Jun 6
  22. Tenedini E, Artuso L, Bernardis I, Artusi V, Percesepe A, De Rosa L, Contin R, Manfredini R, Pellecani G, Giannetti A, Pagani J, De Luca M, Tagliafico E. Amplicon-based NGS: an effective approach for the molecular diagnosis of Epidermolysis Bullosa. Br J Dermatol. 2015 Sep;173(3):731-8 doi: 10.1111/bjd.13858. Epub 2015 Jul 29.
  23. Pellegrini G, De Luca M, Eyes on the prize: limbal stem cells and corneal restoration, Cell Stem Cell. 2014 Aug 7;15(2):121-2. doi: 10.1016/j.stem.2014.07.011.
  24. Bianco P, Cattaneo E, De Luca M, Pani L. Stamina therapies: Let the record stand. Nature. 2014 Feb 27;506(7489):434. doi: 10.1038/506434c.
  25. Pellegrini G, Rama P, Di Rocco A, Panaras A, De Luca M. Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine. Stem Cells. 2014 Jan;32(1):26-34. doi: 10.1002/stem.1517.
  26. De Rosa L, Carulli S, Cocchiarella F, Quaglino D, Enzo E, Franchini E, Giannetti A, De Santis G, Recchia A, Pellegrini G, De Luca M. Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. Stem Cell Reports. 2014 Jan 14;2(1):1-8. doi: 10.1016/j.stemcr.2013.11.001. eCollection 2014.
  27. Pellegrini G, Rama P, Matuska S, Lambiase A, Bonini B, Pocobelli A, Gisoldi Colabelli R, Spadea L, Fasciani R, Ballestrazzi E, Vinciguerra P, Rosetta P, Tortori A, Nardi M, Gabbriellini G, Traverso CE., Macaluso C, Losi L, Percesepe A, Venturi B, Corradini F, Panaras A, Di Rocco A, Guatelli P, De Luca M. Biological parameters determining the clinical outcome of cultured limbal stem cells. Regen Med. 2013 Sep;8(5):553-67. doi: 10.2217/rme.13.43. Epub 2013 Jun 3.
  28. Carulli S, Contin R, De Rosa L, Pellegrini G, De Luca M. The long and winding road that leads to a cure for epidermolysis bullosa. Regen Med. 2013 Jul;8(4):467-81. doi: 10.2217/rme.13.33.
  29. Bianco P, Barker R, Brüstle O, Cattaneo E, Clevers H, Daley GQ, De Luca M, Goldstein L, Lindvall O, Mummery C, Robey PG, Sattler de Sousa E Brito C, Smith A. Regulation of stem cell therapies under attack in Europe: for whom the bell tolls. EMBO J. 2013 May 29;32(11):1489-95. doi: 10.1038/emboj.2013.114. Epub 2013 May 3.
  30. De Rosa L, De Luca M. Cell biology: Dormant and restless skin stem cells. Nature. 2012 Sep 13;489(7415):215-7. doi: 10.1038/489215a.
  31. Corradini F, Venturi B, Pellegrini G, De Luca M. Methods for characterization/manipulation of human corneal stem cells and their applications in regenerative medicine. Methods Mol Biol. 2012;916:357-72. doi: 10.1007/978-1-61779-980-8_26.
  32. Pellegrini G, Rama P, De Luca M. Vision from the right stem. Trends Mol Med. 2011 Jan;17(1):1-7 Epub 2010 Nov 11
  33. Rama P, Matuska S, Paganoni G, Spinelli A. De Luca M, Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med. 2010 Jul 8;363(2):147-55. doi: 10.1056/NEJMoa0905955. Epub 2010 Jun 23.
  34. Pellegrini G, De Luca M. Human embryonic stem-cell derived keratinocytes: how close to clinics?. Cell Stem Cell. 2010 Jan 8;6(1):8-9. doi: 10.1016/j.stem.2009.12.002.
  35. Lambiase A, Micera A, Pellegrini G, Merlo D, Rama P, De Luca M, Bonini S, Bonini S. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression. Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4622-30. doi: 10.1167/iovs.08-2716. Epub 2009 Apr 30.
  36. De Luca M, Pellegrini G, Mavilio F. Gene therapy of inherited skin adhesion disorders: A critical overview. Br J Dermatol. 2009 Jul;161(1):19-24. doi: 10.1111/j.1365-2133.2009.09243.x. Epub 2009 Apr 20.
  37. Ahrlund-Richter L, De Luca M, Marshak DR, Munsie M, Veiga A, Rao M, Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell. 2009 Jan 9;4(1):20-6. doi: 10.1016/j.stem.2008.11.012. Epub 2008 Dec 8.
  38. Pellegrini G, Rama P, Mavilio F, De Luca M. Epithelial stem cells in corneal regeneration and epidermal gene therapy. J Pathol. 2009 Jan;217(2):217-28. doi: 10.1002/path.2441.
  39. Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, Kim HO, Lee HP, Levy- Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ. New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research. Cell Stem Cell. 2008 Dec 4;3(6):607-9. doi: 10.1016/j.stem.2008.11.009.
  40. De Luca M, Pellegrini G, Mavilio F. Gene therapy of inherited skin adhesion disorders. Drug Discovery Today: Therapeutic Strategies. 2008 Dec;5(4):249-254. Doi: 10.1016/j.ddstr.2009.04.001.
  41. Di Nunzio F, Maruggi G, Ferrari S, Di Iorio E, Poletti V, Garcia M, Del Rio M, De Luca M, Larcher F, Pellegrini G, Mavilio F. Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors. Mol Ther. 2008 Dec;16(12):1977-85. doi: 10.1038/mt.2008.204. Epub 2008 Sep 23.
  42. Pellegrini G, De Luca M, Arsenijevic Y. Towards therapeutic application of ocular stem cells. Semin Cell Dev Biol. 2007 Dec;18(6):805-18. Epub 2007 Sep 16.
  43. Barbaro V, Testa A, Di Iorio E, Mavilio F, Pellegrini G, De Luca M . C/EBPd regulates cell cycle and self- renewal of human limbal stem cells. J Cell Biol. 2007 Jun 18;177(6):1037-49. Epub 2007 Jun 11.
  44. Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, Maruggi G, Ferrari G, Bonini C, Capurro S, Conti A, Magnoni C, Giannetti A, De Luca M. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006 Dec;12(12):1397-402. Epub 2006 Nov 19.
  45. Barbaro V, Di Iorio E, Ferrari S, Bisceglia L, Ruzza A, De Luca M, Pellegrini G. Expression of VSX1 in human corneal keratocytes during differentiation to myofibroblasts in response to wound healing. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5243-50.
  46. Di Iorio E, Barbaro V, Ferrari S, Ortolani C, De Luca M, Pellegrini G. Q-FIHC: quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells. Microsc Res Tech. 2006 Dec;69(12):983-91.
  47. Vetrini F, Tammaro R, Bondanza S, Surace EM, Auricchio A, De Luca M, Ballabio A, Marigo V. Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides. Hum Mutat. 2006 May;27(5):420-6.
  48. Ferrari S, Pellegrini G, Matsui T, Mavilio F, De Luca M. Towards a gene therapy clinical trial for epidermolysis bullosa. Rev Recent Clin Trials. 2006 May;1(2):155-62.
  49. Ferrari S, Pellegrini G, Matsui T, Mavilio F, De Luca M. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa. Expert Opin Biol Ther. 2006 Apr;6(4):367-78.
  50. De Luca M, Pellegrini G, Green H. Regeneration of squamous epithelia from stem cells of cultured grafts. Regen Med. 2006 Jan;1(1):45-57.
  51. Volpi N, Maccari F, Ferrari S, De Luca M, Pellegrini G. Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection. Anal Biochem. 2005 Jul 15;342(2):200-5.
  52. Di Iorio E, Barbaro V, Ruzza A, Ponzin D, Pellegrini G, De Luca M. Isoforms of DNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9523-8. Epub 2005 Jun 27.
  53. Ferrari S, Pellegrini G, Mavilio F, De Luca M. Gene therapy approaches for epidermolysis bullosa. Clin Dermatol. 2005 Jul-Aug;23(4):430-6.
  54. Lemoli RM, Bertolini F, Cancedda R, De Luca M, Del Santo A, Ferrari G, Ferrari S, Martino G, Mavilio F, Tura S. Stem cell plasticity: time for a reappraisal? Haematologica. 2005 Mar;90(3):360-81.
  55. Pellegrini G, Dellambra E, Paterna P, Golisano O, Traverso CE, Rama P, Lacal P, De Luca M. Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes. Eur J Cell Biol. 2004 Dec;83(11-12):691-700.
  56. Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, Kuhn S, Piazza P, Luci A, Atzori F, De Luca M. Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis. Br J Dermatol. 2004 Apr;150(4):715-21.
  57. Abbruzzese C, Kuhn U, Molina F, Rama P, De Luca M. Novel mutations in the CHST6 gene causing macular corneal dystrophy. Clin Genet. 2004 Feb;65(2):120-5.
  58. Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, Paterna P, Sonego G, Gobello T, Atzori F, Piazza P, Luci A, De Luca M. Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol. 2003 Oct;139(10):1303-10.
  59. Quast T, Wehner S, Kirfel G, Jaeger K, De Luca M, Herzog V. sAPP as a regulator of dendrite motility and melanin release in epidermal melanocytes and melanoma cells. FASEB J. 2003 Sep;17(12):1739-41. Epub 2003 Jul 3.
  60. Rheinwald JG, Hahn WC, Ramsey MR, Wu JY, Guo Z, Tsao H, De Luca M, Catricalà C, O’Toole KM. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol. 2002 Jul;22(14):5157-72.
  61. Schiaffino MV, Dellambra E, Cortese K, Baschirotto C, Bondanza S, Clementi M, Nucci P, Ballabio A, Tacchetti C, De Luca M. Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes. Hum Gene Ther. 2002 May 20;13(8):947-57.
  62. De Luca M, Dellambra E, Pellegrini G, Guerra L, Bondanza S, Mavilio F. Toward gene therapy of junctional epidermolysis bullosa (JEB). European Journal of Human Genetics. 2002;10: 58.
  63. Rama P, Bonini S, Lambiase A, Golisano O, Paterna P, De Luca M, Pellegrini G. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation. 2001 Nov 15;72(9):1478-85.
  64. Dellambra E, Prislei S, Salvati AL, Madeddu ML, Golisano O, Siviero E, Bondanza S, Cicuzza S, Orecchia A, Giancotti FG, Zambruno G, De Luca M. Gene correction of integrin beta4-dependent pyloric atresia-junctional epidermolysis bullosa keratinocytes establishes a role for beta4 tyrosines 1422 and 1440 in hemidesmosome assembly. J Biol Chem. 2001 Nov 2;276(44):41336-42. Epub 2001 Aug 24.
  65. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3156-61.
  66. D’Addio M, Pizzigoni A, Bassi MT, Baschirotto C, Valetti C, Incerti B, Clementi M, De Luca M, Ballabio A, Schiaffino MV. Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet. 2000 Dec 12;9(20):3011-8.
  67. Dellambra E, Pellegrini G, Guerra L, Ferrari G, Zambruno G, Mavilio F, De Luca M. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa. Hum Gene Ther. 2000 Nov 1;11(16):2283-7.
  68. Taichman LB, Khavari PA, De Luca M. Introductory remarks. Hum Gene Ther. 2000 Nov 1;11(16):2245.
  69. Guerra L, Capurro S, Melchi F, Primavera G, Bondanza S, Cancedda R, Luci A, De Luca M, Pellegrini G. Treatment of “stable” vitiligo by Timedsurgery and transplantation of cultured epidermal autografts. Arch Dermatol. 2000 Nov;136(11):1380-9.
  70. Dellambra E, Golisano O, Bondanza S, Siviero E, Molinari M, Lacal P, D’Atri S, De Luca M. Downregulation of 14-3-3s prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol. 2000 May 29;149(5):1117-30.
  71. Foehr ED, Tatavos A, Tanabe E, Raffioni S, Goetz S, Dimarco E, De Luca M, Bradshaw RA. Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembrane domains in PDGFR/DDR/TrkA chimeric receptors. FASEB J. 2000 May;14(7):973-81.
  72. Pellegrini G, Ranno R, Stracuzzi G, Bondanza S, Guerra L, Zambruno G, Micali G, De Luca M. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation. 1999 Sep 27;68(6):868-79.
  73. Chistolini P, De Angelis G, De Luca M, Pellegrini G, Ruspantini I. Analysis of the mechanical properties of in vitro reconstructed epidermis: preliminary results. Med Biol Eng Comput. 1999 Sep;37(5):670-2.
  74. Schiaffino MV, d’Addio M, Alloni A, Baschirotto C, Valetti C, Cortese K, Puri C, Bassi MT, Colla C, De Luca M, Tacchetti C, Ballabio A. Ocular albinism: evidence for a defect in an intracellular signal transduction system. Nat Genet. 1999 Sep;23(1):108-12.
  75. Pellegrini G, Golisano O, Paterna P, Lambiase A, Bonini S, Rama P, De Luca M. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol. 1999 May 17;145(4):769-82.
  76. Pellegrini G, Bondanza S, Guerra L, De Luca M. Cultivation of human keratinocyte stem cells: current and future clinical applications. Med Biol Eng Comput. 1998 Nov;36(6):778-90.
  77. Vailly J, Gagnoux-Palacios L, Dell’Ambra E, Roméro C, Pinola M, Zambruno G, De Luca M, Ortonne JP, Meneguzzi G. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther. 1998 Oct;5(10):1322-32.
  78. Dellambra E, Vailly J, Pellegrini G, Bondanza S, Golisano O, Macchia C, Zambruno G, Meneguzzi G, De Luca M. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum Gene Ther. 1998 Jun 10;9(9):1359-70.
  79. Bellini MH, Mathor MB, De Luca M, Cancedda R, Bartolini P. Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes. J Endocrinol Invest. 1998 Jan;21(1):1-6.
  80. Marchisio PC, Trusolino L, De Luca M. Topography and biological role of integrins in human skin. Microsc Res Tech. 1997 Aug 15;38(4):353-60.
  81. Malorni W, Guiducci G, Pasquinelli G, Rivabene R, Re RC., Ramazzotti E, De Luca M, La Placa M, Cenacchi G. HIV-type 1 induces specific cytoskeleton alterations in human epithelial cells in culture. Eur. J. Dermatol. 1997 Jun;7(4): 263-269.
  82. De Luca M, Pellegrini G. The importance of epidermal stem cells in keratinocyte-mediated gene therapy. Gene Ther. 1997 May;4(5):381-3.
  83. De Luca M, Pellegrini G. Corneal epithelial stem-cell transplantation. Lancet. 1997 May 24; 349(9064):1156.
  84. Pellegrini G, Traverso C, Franzi AT, Zingirian M, Cancedda R, De Luca M. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 1997 Apr 5;349(9057):990-3.
  85. Mathor MB, Ferrari G, Dellambra E, Cilli M, Mavilio F, Cancedda R, De Luca M. Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10371-6.
  86. Schiaffino MV, Baschirotto C, Pellegrini G, Montalti S, Tacchetti C, De Luca M, Ballabio A. The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9055-60.
  87. Cenacchi G, Guiducci G, Pasquinelli G, Re MC, Ramazzotti E, Furlini G, Malorni W, De Luca M, Martinelli GN. Early ultrastuctural changes of human keratinocytes after HIV-1 contact: an in vitro study. Eur. J. Dermatol. 1996; 6(3): 213-218 prima stesso riferimento bibliografico di 61!!!!
  88. Dellambra E, Patrone M, Sparatore B, Negri A, Ceciliani F, Bondanza S, Molina F, Cancedda FD, De Luca M. Stratifin, a keratinocyte specific 14-3-3 protein, harbors a pleckstrin homology (PH) domain and enhances protein kinase C activity. J Cell Sci. 1995 Nov;108 ( Pt 11):3569-79.
  89. Ramarli D, Giri A, Reina S, Poffe O, Cancedda R, Varnier O, Tridente G, De Luca M. HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation. J Invest Dermatol. 1995 Nov;105(5):644-7. Diverso da quello nel CV
  90. Zambruno G, Marchisio PC, Marconi A, Vaschieri C, Melchiori A, Giannetti A, De Luca M. Transforming growth factor-b1 modulates b1 and b5 integrin receptors and induces the de novo expression of the avb6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol. 1995 May;129(3):853-65.
  91. De Luca M, Pellegrini G, Zambruno G, Marchisio PC. Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J Dermatol. 1994 Nov;21(11):821-8.
  92. Giannelli G, Savoia P, Schiraldi O, Lospalluti M, De Luca M, Marchisio PC, Quaranta V. Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors. Hepatology. 1994 Jul;20(1 Pt 1):56-65.
  93. De Luca M. Keratinocyte-melanocyte interactions in in vitro reconstituted human epidermis. Chron. Derm. 1994;IV:6, 935-940.
  94. Di Marco E, Cutuli N, Guerra L, Cancedda R, De Luca M. Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. J Biol Chem. 1993 Nov 15;268(32):24290-5.
  95. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, De Luca M. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem. 1993 Oct 25;268(30):22838-46.
  96. Romagnoli G, De Luca M, Faranda F, Franzi AT, Cancedda R. One-step treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. J Urol. 1993 Oct;150(4):1204-7.
  97. De Luca M, Siegrist W, Bondanza S, Mathor M, Cancedda R, Eberle AN. Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors. J Cell Sci. 1993 Aug;105 ( Pt 4):1079-84.
  98. Zambruno G, Marchisio PC, Melchiori A, Bondanza S, Cancedda R, De Luca M. Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes. J Cell Sci. 1993 May;105 ( Pt 1):179-90.
  99. Marchisio PC, Cremona O, Savoia P, Pellegrini G, Ortonne JP, Verrando P, Burgeson RE, Cancedda R, De Luca M. The basement membrane protein BM-600/nicein codistributes with kalinin and the integrin alpha 6 beta 4 in human cultured keratinocytes. Exp Cell Res. 1993 Apr;205(2):205-12.
  100. Cancedda R, De Luca M. Tissue engineering for clinical application. Year Immunol. 1993;7:193-8.
  101. Rugolo M, Mastrocola T, De Luca M, Romeo G, Galietta LJ. A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording. Biochim Biophys Acta. 1992 Nov 23;1112(1):39-44.
  102. De Luca M, Pellegrini G, Bondanza S, Cremona O, Savoia P, Cancedda R, Marchisio PC. The control of polarized integrin topography and the organization of adhesion-related cytoskeleton in normal human keratinocytes depend upon number of passages in culture and ionic environment. Exp Cell Res. 1992 Sep;202(1):142-50.
  103. Pellegrini G, De Luca M, Orecchia G, Balzac F, Cremona O, Savoia P, Cancedda R., Marchisio PC, Expression, topography and function of integrin receptors is severely altered in keratinocytes from involved and uninvolved psoriatic skin. J Clin Invest. 1992 Jun;89(6):1783-95.
  104. Barreca A, De Luca M, Del Monte P, Bondanza S, Damonte G, Cariola G, Di Marco E, Giordano G, Cancedda R, Minuto F. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol. 1992 May;151(2):262-8.
  105. De Luca M, Albanese E, Cancedda R, Viacava A, Faggioni A, Zambruno G, Giannetti A. Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study. Arch Dermatol. 1992 May;128(5):633-8.
  106. Gherzi R, Melioli G, De Luca M, D’Agostino A, Distefano G, Guastella M, D’Anna F, Franzi AT, Cancedda R. “HepG2/erythroid/brain” type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis. J Cell Physiol. 1992 Mar;150(3):463-74.
  107. De Luca M, Bondanza S, Cancedda R, Tamisani AM, Di Noto C, Muller L, Dioguardi D, Brienza E, Calvario A, Zermani R, et al. Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: a multicentre study in the treatment of children. Burns. 1992;18 Suppl 1:S16-9. È un articolo?
  108. De Luca M, Cancedda R. Culture of human epithelium. Burns. 1992;18 Suppl 1:S5-10. È un articolo?
  109. Pellegrini G, Gherzi R, Franzi AT, D’Anna F, De Luca M, Cancedda R. In vitro reconstitution of differentiated human epithelia. ATLA. 1992; 20:95-102.
  110. Mastrocola T, De Luca M, Rugolo M. Characterization of chloride transport pathways in cultured human keratinocytes. Biochim Biophys Acta. 1991 Nov 21;1097(4):275-82.
  111. Di Marco E, Marchisio PC, Bondanza S, Franzi AT, Cancedda R, De Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem. 1991 Nov 15;266(32):21718-22.
  112. Gherzi R, Melioli G, De Luca M, D’Agostino A, Guastella M, Traverso CE, D’Anna F, Franzi AT, Cancedda R. High expression levels of the “erythroid/brain” type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture. Exp Cell Res. 1991 Jul;195(1):230-6.
  113. Galietta LJ, Barone V, De Luca M, Romeo G. Characterization of chloride and cation channels in cultured human keratinocytes. Pflugers Arch. 1991 Mar;418(1-2):18-25.
  114. Marchisio PC, Bondanza S, Cremona O, Cancedda R, De Luca M. Polarized expression of integrin receptors (alpha 6 beta 4, alpha 2 beta 1, alpha 3 beta 1, and alpha v beta 5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes. J. Cell Biol. 1991 Feb;112(4):761-73.
  115. Rugolo M, De Luca M, Mastrocola T. Chloride transport pathways in human keratinocytes. Adv Exp Med Biol. 1991;290:297-304; discussion 304-5.
  116. Marchisio PC, Cancedda R, De Luca M. Structural and functional studies of integrin receptors in cultured human keratinocytes. Cell Differ Dev. 1990 Dec 2;32(3):355-9.
  117. De Luca M, Albanese E, Megna M, Cancedda R, Mangiante PE, Cadoni A, Franzi AT. Evidence that human oral epithelium reconstituted in vitro and transplanted onto patients with defects in the oral mucosa retains properties of the original donor site. Transplantation. 1990 Sep;50(3):454-9.
  118. De Luca M, Tamura RN, Kajiji S, Bondanza S, Rossino P, Cancedda R, Marchisio PC, Quaranta V. Polarized integrin mediates human keratinocyte adhesion to basal lamina. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6888-92.
  119. Romagnoli G, De Luca M, Faranda F, Bandelloni R, Franzi AT, Cataliotti F, Cancedda R. Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. N Engl J Med. 1990 Aug 23;323(8):527-30.
  120. De Luca M, Albanese E, Bondanza S, Megna M, Ugozzoli L, Molina F, Cancedda R, Santi PL, Bormioli M, Stella M, et al. Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns. 1989 Oct;15(5):303-9.
  121. De Luca M, D’Anna F, Bondanza S, Franzi AT, Cancedda R. Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. J Cell Biol. 1988 Nov;107(5):1919-26.
  122. De Luca M, Franzi AT, D’Anna F, Zicca A, Albanese E, Bondanza S, Cancedda R. Coculture of human keratinocytes and melanocytes: differentiated melanocytes are physiologically organized in the basal layer of the cultured epithelium. Eur J Cell Biol. 1988 Apr;46(1):176-80.
  123. D’Anna F, De Luca M, Cancedda R, Zicca A, Franzi AT. Elutriation of human keratinocytes and melanocytes from in vitro cultured epithelium. Histochem. J. (J. Mol. Histol.) 1988;20:674-678.
  124. Consiglio E. Acquaviva AM, Formisano S, Liguoro D, Gallo A, Vittorio T, Santisteban P, De Luca M, Shifrin S, Yeh HJ et al. Characterization of phosphate residues on thyroglobulin. J Biol Chem. 1987 Jul 25;262(21):10304-14.
  125. Franzi AT, D’Anna F, Zoli S, Albanese E, De Luca M, Cancedda R. [Separation, by elutriation, of human keratinocytes cultured in vitro – article in Italyn]. Boll Soc Ital Biol Sper. 1987 May 31;63(5):391-7.
  126. Chan J, Santisteban P, De Luca M, Isozaki O, Grollman E, Kohn L. TSH receptor structure. Acta Endocrinol Suppl (Copenh). 1987;281:166-72.
  127. Kohn LD, Alvarez F, Marcocci C, Kohn AD, Corda D, Hoffman WE, Tombaccini D, Valente WA, De Luca M, Santisteban P, et al. Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves’ disease. Ann N Y Acad Sci. 1986;475:157-73.
  128. Kohn LD, Chan J, Alvarez F, Corda D, Hoffman WE, Kohn AD, Rotella C, Isosaki O, Santisteban P, De Luca M, Grollman EF. Mono-clonal Antibodies to the Thyrotropin (TSH) Receptor in the study of Graves’ Disease: Idiotypes and Antiidiotypes. Clinical Immunology Newsletter. 1986; 7:182-185.
  129. Monaco F, Carducci C, De Luca M, Andreoli M, Dominici R. Human undifferentiated thyroid carcinoma synthesizes and secretes 19S thyroglobulin. Cancer. 1984 Jul 1;54(1):79-83.
  130. Rotella CM, Tanini A, Consiglio E, Shifrin S, De Luca M, Toccafondi R, Kohn LD. Specificity of thyroglobulin interactions with thyroid cells and membranes. Biochem Biophys Res Commun. 1983 Aug 12;114(3):962-8.
  131. Monaco F, De Luca M, Carducci C, Pontecorvi A, D’Armiento M, Roche J. Sur l’inhibition de la biosynthese de la thyroglobuline dans le corps thyroide du rat par l’isoniazide. C R Seances Soc Biol Fil. 1982;176(5):613-8.
  132. Monaco F, Pontecorvi A, De Luca M, De Pirro R, D’Armiento M, Roche J. Inhibition de la biosynthese de la thyroglobuline par le propranolol chez le rat. C R Seances Soc Biol Fil. 1982;176(5):607-12.
BOOK CHAPTERS
  1. Corradini F, Zattoni M, Rama P, De Luca M, Pellegrini G. Corneal Bioengineering. In: Orlando G. Regenerative Medicine Applications in Organ Transplantation. Elsevier, Amsterdam, 2014, 829-840. ISBN: 9780123985231 | 9780123985231
  2. Pellegrini G, De Luca M. Facciamo il punto sulla medicina rigenerativa della superficie oculare. In: AA.VV. Occhio & cellule staminali. Società Oftalmologica Italyna, Roma, 2006, 31-56. ISBN: 10-88-89629-20-07
  3. Pellegrini G, De Luca M. Terapia cellulare e genica con cheratinociti umani coltivati. In: Candedda R, Pietrabissa R. Ingegnaria dei tessuti biologici. Patron Editore, Bologna, 2002, 239-254 ISBN: 8855526642
  4. De Luca M, Guerra L, Dellambra E, Pellegrini G. Keratinocyte-mediated cell and gene therapy. In: Horch R.E., Munster AM, Achauer BM. Cultured human keratinocytes and tissue engineered skin substitutes. Georg Thieme Verlag, Stuttgart Tubingen, 2001, (28), 72-82 ISBN: 3-13-130161-9
  5. De Luca M, Guerra L, Pellegrini G. Applicazioni cliniche dei cheratinociti umani normali coltivati in vitro. In: Papi M, Guarnera G. L’ulcera cutanea degli arti inferiori. Monti, Saronno, 1988, 217-232 ISBN: 8886881150
  6. De Luca M, Pellegrini G, Zambruno G. The epidermal keratinocyte. In: Harris A. Epithelial Cell Culture. Cambridge University Press, Cambridge, 1996, 122-144 ISBN: 0521550238
  7. De Luca M, Bondanza S, Di Marco E, Marchisio PC, D’Anna F, Franzi AT, Cancedda R. Keratinocyte melanocyte interactions in in vitro reconstituted normal human epidermis. In: Leigh I, Watt F, Lane B (Eds.). The Keratinocyte Handbook. Cambridge University Press, Cambridge, 1994, 95-108.
  8. Marchisio PC, De Luca M. Role of integrins in cell-substratum attachment and polarity of normal and neoplastic epithelial cells. In: Citi S (Ed.). Molecular mechanisms of epithelial cell junctions: from development to disease. R. G. Landes Co Biomedical Publisher, Austin TX, 1994, 285-295.
  9. Akamizu T, De Luca M, Kohn LD. Thyrotropin Receptor: Characterization and Purification. In: Litwack A. Receptor Purification. The Humana Press Inc. Totowa, NJ, 1990, (1), 217-247 ISBN: 0896031675
  10. De Luca M, Albanese E, Cancedda R. Human epidermis culture for the treatment of burned patients: a multicenter Italyn experience. In: Teepe RGC (Ed.). Clinical use of cultured epithelium in surgery and dermatology. Medical and Scientific Conferences Ltd, 1988, 29-32.
  11. Chan J, De Luca M, Santisteban P, Isosaki O, Shifrin S, Aloj SM, Grollman EF, Kohn LD. Nature of thyroid autoantigens: the TSH receptor. In: Pinchera A, Ingbar SH, Mc Kenzie JM, Fenzi GF. Thyroid Autoimmunity. Plenum Press New York and London, 1987, 11-26 ISBN: 0306427621
  12. Kohn LD, Valente WA, Cheng A, Tombaccini D, Chan J, Corda D, Kohn AD, Rotella CM, Marcocci C, Santisteban P, De Luca M, Bone E, Grollman EF. Monoclonal Antibodies to the thyrotropin (TSH) receptor in the studies of Graves’ disease. In: Forti G, Serio M, Lipsett M. Serono Symposium Monoclonal Antibodies: Basic Principles, Experimental and Clinical Application in Endocrinology. Raven Press, New York, 1986, (30), 232-244 ISBN: 0881671983
  13. Kohn LD, De Luca M, Santisteban P, Shifrin S, Yeh H, Formisano S, Consiglio E. Thyroglobulin interaction with thyroid membranes: implications for regulation of thyroid hormone formation. In: Eggo MC, Burrow GN. Thyroglobulin – the Prothyroid Hormone. Progress in Endocrine Research and Therapy. Raven Press, New York, 1985, 171-190 ISBN: 0881670731
  14. Kohn LD, Tombaccini D, De Luca M, Bifulco M, Grollman EF, Valente WA. Monoclonal antibodies and the thyrotropin receptor”. In Graves MF (Ed.). Monoclonal Antibodies to Receptors. Chapman and Hall Ltd., 1985, 201-234.
  15. Kohn LD, Rotella CM, Marcocci C, Toccafondi R, Pinchera A, Tombaccini D, Valente WA, De Luca M, Grollman EF. Monoclonal antibodies and autoimmune thyroid diseases. In: Pinchera A, Doria G, Dammacco F, Bargellesi (Eds.). Monoclonal Antibodies ‘84: Biological and Clinical Applications. Kurtis, 1985, 169-199 ISBN: 8885030041
  16. Kohn LD, Valente WA, Laccetti P, Marcocci C, De Luca M, Ealey PA, Marshall NJ, Grollman EF. Monoclonal antibodies as probes of thyrotropin receptor structure. In: Venter JC, Fraser CM, Lindstrom JM. Monoclonal and Anti-idiotypic Antibodies: Probes for Receptor Structure and Function. Alan R. Liss, New York. 1984, (4), 85-116 ISBN: 0845137034

PATENTS

  1. De Luca M., Pellegrini G. Usi terapeutici di lembi di cellule geneticamente modificate. Nazional patent application n.102017000104587 OC/133447
  2. Pellegrini G., Alessandrini A., De Luca M., In vitro method for producing a flap of genetically modified cells on fibrin substrate, Patent Application n. 102017000094210, Aug. 17 2017.
  3. De Luca M. and Pellegrini G., In vitro reconstituted sheets of human corneal epithelium and method of producing the same, EP Patent 1451302, May 28, 2008
  4. De Luca M. and Pellegrini G., Reconstructed laminae of human epithelium corneae and method of producing the same, US Patent 6,610,538, Aug. 26, 2003
  5. De Luca M. and Pellegrini G., Case for the protection and the transportation of epidermis or skin grafts cultivated in vitro from a skin graft cut from a donor, US Application 2003/034267, Feb. 20, 2003
  6. De Luca M. and Dellambra E., Method to obtain immortalized cell lines form primary cultured human keratinocytes, US Patent 2001/0018213, Aug. 30, 2001
  7. De Luca M. and Dellambra E., Method of immortalization of human keratinocytes by down-regulation of 14-3-3 sigma expression, EP Application 1127942, Aug. 29, 2001.
  8. Geraci G., De Rosa M., Rossi M., Cancedda R., De Luca M. and Pellegrini G., Cryoprotective acqueous solution useful for the preservation of in vitro cultured epithelial cells, EP Patent 0671877, Aug. 19, 1998.
  9. Geraci G., De Rosa M., Rossi M., Cancedda R., De Luca M. and Pellegrini G., Cryoprotective acqueous solution useful for the preservation of in vitro cultured epithelial sheets, US Patent 5,670,308, Sep. 23, 1997
  10. Cancedda R. and De Luca M., Epithelium-tubular carrier biostructure and method for the preparation thereof, EP Application 0597810, May 18, 1994.
  11. Cancedda R. and De Luca M., Cryopreserved in vitro cultured epithelial tissue and method, US Patent 5,298,417, Mar. 29 1994.
  12. Cancedda R., De Luca M and Gherzi R., Differentiated ocular surface epithelial cell culture, process for the preparation and carrier for uses thereof, EP Application 0572364, Jan 12, 1993.
  13. Cancedda R. and De Luca M., Method for preserving transplantable sheets of epithelium cultured in vitro, EP Application 0296475, Dec. 28, 1988.

SCIENTIFIC MEETINGS ORGANIZATION

  1. Co-chairman, Science for Democracy, VI World Congress for Freedom of Scientific Research, 25-26 February 2020, Addis Ababa, Ethiopia
  2. Co-chairman, Science for Democracy, V World Congress for Freedom of Scientific Research, 11-13 April 2019 Brussels, Belgium
  3. Co-chairman ISSCR Regional Forum Series 2013, “Stem Cells in Translation”, Firenze, Italy, 15-18 September 2013
  4. Gordon Research Conferences, “Epithelial Differentiation and Keratinization”, Chairman Issue Rising Session, Il Ciocco, Lucca, Italy, 29 May-3 June 2005
  5. Co-chairman international workshop “Tissue Engineering and Cellular Cultures”, Villa Gualino, Torino, 29-30 May 2000
  6. Co-chairman First International Conference “Cutaneous Gene Therapy: Problems and Prospects”, NIH, Bethesda, MD, USA, 23-24 March 2000
  7. Chairman international workshop “Cultured Human Epidermis: Clinical Applications”, I.D.I. Istituto Dermopatico dell’Immacolata, Roma, Italy, 10 October 1997
  8. Chairman EMBO WORKSHOP “Growth and Differentiation of Epithelial Cells”, Santa Margherita Ligure (GE), 10-14 June 1994
  9. Chairman workshop “Adhesion and Extracellular Matrix”, Scuola Superiore di Oncologia e Scienze Biomediche, Santa Margherita Ligure (GE), June 1992

RESEARCH PROJECTS (since 2006)

  1. 2021: Custom-designed gene editing of induced epidermal stem cells for gene therapy of genetic diseases of squamous epithelia (Holo-GT), funded by European Commission (ERC Advanced Grant, 101019289)
  2. 2021: European consortium for communicating gene- and cell-based therapy information (EuroGCT Project)(H2020, 965241)
  3. 2021: “Allele-specific CRISPR- engineered Cpf1 genome editing to treat ocular surface disorder in ectrodactily-ectodermal dysplasia-clefting (EEC) syndrome” funded by Telethon (GGP20088)
  4. 2021: “L’epidermolisi bollosa (EB) a Modena dalla diagnosi alla terapia genica” funded by Debra Südtirol-Alto Adige 5×1000
  5. 2019: “Supercomputing Unified Platform Emilia-Romagna” (SUPER) funded by Regione Emilia-Romagna (CUP E81F18000330007) 
  6. 2019: “Ottimizzazione degli approcci di terapia genica per l’Epidermolisi Bollosa” funded by Debra Südtirol-Alto Adige 5×1000
  7. 2019: “Hologene7 2.0: L’Epidermolisi Bollosa (EB) a Modena dalla diagnosi alla terapia genica” funded by Regione Emilia-Romagna (POR-FESR-2014-2020 CUP E51F18000380009)
  8. 2018: “Hologene 7 come modello di sviluppo di una terapia avanzata a base di cellule staminali geneticamente corrette”, funded by da Debra Südtirol-Alto Adige 5×1000
  9. 2016: “Hologene 7 come modello di sviluppo di una terapia avanzata a base di cellule staminali geneticamente corrette” funded by Emilia-Romagna (POR-FESR-2014-2020 CUP E92I16000220005)
  10. 2014: “European Consortium for Communicating Stem Cell Research” – EUROSTEMCELL funded by European Union (H2020-Adhoc-2014-20 n. 652796)
  11. 2013: “Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector – GENEGRAFT funded by European Union (FP7-HEALTH-2010 n. 261392)
  12. 2013: “Italian Regenerative Medicine Infrastructure (IRMI), a multiregional infrastructure for the development of advanced therapies aimed at organs and tissues regeneration” funded by M.I.U.R. (project n. CTN01_00177_888744)
  13. 2013: “La terapia genica per l’Epidermolisi Bollosa: dalla pre-clinica alla clinica” funded by Fondazione Cassa di Risparmio di Modena
  14. 2013: “Nuove strategie per la medicina rigenerativa” funded by M.I.U.R (PRIN 2010 n. 2010B5B2NL_002)
  15. 2010: “Centro di Medicina Rigenerativa – Tecnopolo di Modena” funded by Emilia-Romagna Region and European Union (Asse 1 POR FESR 2007-2013);
  16. 2008: “Pre-clinical development of gene therapy for epidermolysis bullosa” funded by Italyn Ministry of Health (RF-EMR-2008-1210900)
  17. 2007: “Optimization of stem cell therapy for degenerative epithelial and muscle diseases” – OPTISTEM funded by European Union (FP7-HEALTH-2007 n. 223098)
  18. 2007: “Human epithelial stem cells: molecular characterization and development of clinical applications in regenerative medicine” funded by Emilia-Romagna Region (Progetto Regione-Università area 1b, medicina rigenerativa)
  19. 2006: “Gene therapy of junctional epidermolysis bullosa” funded by The French Muscular Dystrophy Association (CUP E91J10000420007)

TEACHING (COURSES, SEMINARS & WORKSHOPS)

  1. SIGU (Società Italiana di Genetica Umana), Webinar “Medical Genetics Academy SIGU 2022”, 13 October 2022 (remote)
  2. Hydra 2022, XV European Summer School on Stem Cell Biology and Regenerative Medicine, 13-20 September 2022, Hydra, Greece
  3. King’s College London, Randall Seminar Series, 14 June 2022 (remote)
  4. Berlin Institute of Health, BIH Lecture Series, Frontiers in Translational Medicine – Scientific and Structural Challenges, 10 June 2022 (remote)
  5. EXPOSANITA’, Workshop Clust-ER Health, Industrie della Salute e del Benessere,  “Prodotti medicinali per le terapie avanzate: prospettive di sviluppo e industrializzazione”, 12 May 2022, Bologna
  6. Workshop on “Stem Cells and Their Promise for Regenerative Medicine”, 5-6 May 2022, Città del Vaticano
  7. Helmholtz Zentrum Munchen, HDC Hybrid Seminar Series, 15 February 2022 (remote)
  8. UC San Diego Stem Cell Symposium, 10 February 2022, La Jolla, California
  9. Unimore, Lettura Magistrale, XX Modulo del Master in Wound-Care, 28 January 2022 (remote)
  10. Università degli Studi di Torino, Master II Livello “Cellule Staminali in Medicina Rigenerativa e Management della Cell Factory” – Secondo Ciclo, 13 January 2022 (remote)
  11. Utrecht University, PhD Programme on “Cancer Stem Cells and Developmental Biology” (CSnD) and Regenerative Medicine, 14 December 2021 (remote)
  12. Osservatorio Terapie Avanzate (OTA), Il Valore delle Terapie Avanzate in Italia, Presentazione Consensus “Proposta di misure per la determinazione del valore delle Terapie Avanzate in Italia”, 17 November 2021 (remote)
  13. Università di Torino, Workshop del Master di II° Livello “Cellule Staminali in Medicina Rigenerativa e Management della Cell Factory”, sessione “La manipolazione genetica ex vivo – ri-espressione genica”, 18 September 2021 (remote)
  14. European Summer School “Stem cell and Regenerative Medicine”, 14-21 September 2021, Hydra, Greece (CANCELLED)
  15. Sorbonne University, 15 September 2021 (remote)
  16. University of Oxford, “From Laboratory to the Clinic: Novel Approaches to Unmet Needs” Meeting, August 31-September 3, 2021, Oxford, UK
  17. Rare Diseases Summer School, 14-16 July 2021, Zurigo, Svizzera (POSTPONED to 13-15 July 2022)
  18. European Reference Networks (ERN)-SKIN, ERN-SKIN Webinars, EB Thematic Group on Inherited Epidermolysis Bullosa and Skin Fragility Syndromes, 6 July 2021 (remote)
  19. Università di Genova, Cellule staminali epiteliali in terapia cellulare e genica, 9 June 2021 (remote)
  20. Collegio San Carlo,  Ciclo di Seminari di “Etica delle Professioni” , 24 May 2021 (remote)
  21. The San Raffaele Institute for Gene Therapy, Virtual Keynote Lecture, 29 April 2021 (remote)
  22. Brody School of Medicine at East Carolina University, Webex Seminar Series, 16 April 2021 (remote)
  23. Scuola di Giornalismo Walter Tobagi, “Comunicare la Scienza”, Seminar, 25 February 2021 (remote)
  24. Humanitas Research Hospital, Humanitas Seminar Series 2020-21, Milano, 21 January 2021 (remote)
  25. Keele University School of Medicine, Contemporary Medicine Lecture Series, 17 February 2020, Keele, UK
  26. Università di Pavia, Corso di Dottorato di Genetica, Biologia Molecolare e Cellulare, “Translation of basic science research into applications: lessons from gene and cell therapies”, 10 February 2020, Pavia, Italy
  27. Osservatorio Terapie Avanzate, Media tutorial  “Conoscere e comunicare le terapie avanzate: cure rivoluzionarie dalla ricerca medica”, 5 December 2019, Roma, Italy
  28. Oxford Stem Cell Institute Symposium, Celebratory Lecture “Sir Richard Gardner”, 1 November 2019, Oxford (UK)
  29. 2019 European Summer School “Stem cell and Regenerative Medicine”, 15-22 September 2019, Hydra, Greece
  30. Basel Life 2019, 9-12 September 2019, Basel, Switzerland
  31. Institut Pasteur, Advances in Stem Cell Biology Course 2018-2019, 2 July 2019, Paris, France
  32. Scuola di Giornalismo Walter Tobagi, Seminar, 23 May 2019, Milano, Italy
  33. Ordine dei Medici Chirurghi e degli Odontoiatri della Provincia di Modena, Scuola di Etica, Bioetica e Deontologia medica, V course, 12 April 2019, Modena, Italy
  34. ESGCT, European Society of Gene and Cell Therapy Spring School, 3-5 April 2019, Napoli, Italy
  35. Università di Teramo, Lezione nella Giornata Annuale di confronto sulle attività di ricerca dei dottorandi regionali del corso di Biotecnologie, 15 February 2019, Teramo, Italy
  36. Università di Foggia, Lezione nel Corso di Laurea internazionale in Scienze e Tecnologie Biomolecolari, Foggia, 14 February 2019, Foggia, Italy
  37. Accademia dei Lincei, Conferenza di Classe, 8 February 2019, Roma, Italy
  38. Biomedicum Helsinki Seminar series, “Regenerative medicine by somatic stem cells: the paradigm of epithelial stem cells”, 4 February 2019, Helsinki, Finland
  39. University College Dublin, Conway Class Seminar Series, 29 January 2019, Dublin, Ireland
  40. Fondazione Chiara D’Onofrio e Università di Tor Vergata, Lectio magistralis Chiara D’Onofrio 2019, 17 January 2019, Roma, Italy
  41. University of Utrecht, “Introduction to Stem Cell Biology” Course, 10 January 2019, Utrecht, Netherlands
  42. Università di Torino, Scientific Simposium, “New frontiers in Transplantation, Regenerative Medicine and Artificial Life”, 24 November 2018, Torino, Italy
  43. Wellcome Genome Campus, Keynote Speaker, Advanced Course “Genomic for Dermatology”, 19 November 2018, Hinxton, Cambridge, UK
  44. Oxford Stem Cell Institute (OSCI) Annual Symposium, 12-13 November 2018, Oxford, UK
  45. Università degli Studi di Milano, Seminario per gli studenti del corso di Biologia del differenziamento e terapie cellulari, 6 November 2018, Milano, Italy
  46. University of Manchester, MaRMN Seminar, 11 October 2018, Manchester, UK
  47. International Centre for Genetic Engineering and Biotechnology (ICGEB), Seminar “Combined cell and gene therapy of Epidermolysis Bullosa shed light on human epidermal stem cells”, 3 October 2018, Trieste, Italy
  48. Phd Week, Lectio magistralis “Epithelial stem cells in cell and gene therapy”, 25 September 2018, Trieste, Italy
  49. TIGEM, Seminario “Epithelial stem cells in combined cell and gene therapy”, 5 June 2018, Napoli, Italy
  50. Università degli Studi di Cagliari, Seminar “Ricerca Biomedica e Problematiche Etiche, Giuridiche e Sociali”, 17 March 2018, Cagliari, Italy
  51. Paul Ehrlich Institute, Seminar, 7 March 2018, Langen, Germany
  52. Institute for Research in Biomedicine (IRB) Barcelona, Seminar, 23 February 2018, Barcellona, Spain
  53. Accademia Nazionale dei Lincei, Seminar “La terapia genica con cellule staminali per le malattie della pelle”, 19 February 2018, Roma, Italy
  54. Accademia Nazionale Dei Lincei, Centro Linceo Interdisciplinare “Beniamino Segre”, XLV Seminario sulla Evoluzione biologica e i grandi problemi della biologia, “Le Cellule staminali nella medicina rigenerativa e nello sviluppo dei tumori”,19-20 February 2018, Roma, Italy
  55. Massachusetts General Hospital, Seminar, 14 February 2018, Boston, USA
  56. Columbia University, Seminar, 13 February 2018, New York City, USA
  57. Workshop ”The Product is the process – Is it? Quality aspects in the production of ATMP”, 7 November 2017, Berlin, Germany
  58. Università degli Studi di Milano, Seminario per gli studenti del corso di Biologia del differenziamento e terapie cellulari, 2 November 2017, Milano, Italy
  59. 2017 European Summer School, “Stem cell and Regenerative Medicine”, 10-17 September 2017, Hydra, Greece
  60. Scuola Superiore Sant’Anna, Lectio magistralis nell’ambito del programma di seminari “Orizzonti in Medicina e Biologia”, 22 March 2017, Pisa, Italy
  61. Università del Salento, Seminar, 22 November 2016, Lecce, Italy
  62. Accademia Medica di Roma, Giornata in memoria di Paolo Bianco, 10 November 2016, Roma, Italy
  63. Institute of Reconstructive Neurobiology, University of Bonn, LIFE & BRAIN Center, Seminar “State of translational activities at the various sites”, 3 November 2016, Bonn, Germany
  64. EuroStemCell, 2016 European Summer School, “Stem Cells and Regenerative Medicine”, 11-18 September 2016, Hydra, Greece
  65. Scuola di Specializzazione in Malattie dell’Apparato Respiratorio, Summer Meeting 2016, 1 July 2016, Pavullo nel Frignano (MO), Italy
  66. Institut Pasteur & Revive, 4th Advances in Stem Cell Biology Course, 28 June 2016, Paris, France
  67. Università degli Studi di Modena e Reggio Emilia, Incontro con gli studenti sul tema “Il farmaco dalla ricerca di base alla terapia: sinergie tra Accademia e Impresa. Realtà e prospettive occupazionali”, “Cellule staminali e medicina rigenerativa”, 20 May 2016, Modena, Italy
  68. Università degli Studi Federico II, Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Seminario “Epithelial Stem Cells and Regenerative Medicine”, 17 May 2016, Napoli, Italy
  69. Università Federico II di Napoli, Seminario dal titolo “Cellule staminali in medicina rigenerativa: il paradigma delle staminali epiteliali”, 3 May 2016, Napoli, Italy
  70. Università degli Studi di Milano, Seminario per gli studenti del corso di Biologia del differenziamento e terapie cellulari, 18 April 2016, Milano, Italy
  71. University of Copenhagen, The Danish Stem Cell Center, DanStem Seminar Series, 16 March 2016, Copenhagen, Denmark
  72. CNR, “Stem Cells: from embryo to therapeutical applications”, 15 February 2016, Roma, Italy
  73. Revive 2016, 4 February 2016, Paris, France
  74. A.S.L. Biella, Ciclo di incontri “La Scienza e le sue frontiere”, “Staminali dalla speranza alla cura per l’epidermolisi bollosa e le lesioni della cornea”, 21 January 2016, Biella, Italy
  75. Università di Modena e Reggio Emilia, Seminario per gli specializzandi in otorinolaringoiatria della Regione Emilia-Romagna, 18 January 2016, Modena, Italy
  76. Collegio Cairoli, Giovedì del collegio Cairoli, “Cellule staminali tra scienza, pseudoscienza ed etica”, 26 November 2015, Pavia, Italy
  77. Collegio Universitario Fondazione San Carlo, Ciclo di Seminari “Etica ed Esperienza: le professioni come luogo di apprendimento morale”, Seminario “Staminali: tra etica, scienza e pseudoscienza”, 29 April 2015, Modena, Italy
  78. Università di Milano, Seminar, 13 April 2015, Milano, Italy
  79. Scuola Superiore di Studi Avanzati Sapienza, Seminar “La Scienza della buona Ricerca Clinica”, Roma, 31 March 2015, Italy
  80. Università di Catania, Seminar “Epithelial stem cells and regenerative medicine”, European Frontiers in Ocular Pharmacology – Tenth Series,6 March 2015, Catania, Italy
  81. Centre for Integrative Biology, Seminar “Regenerative Medicine by somatic stem cell: the paradigm of epithelial stem cells”,18 December 2014, Trento, Italy
  82. Centre for Regenerative Medicine Therapies TU Dresden, Seminar “Regenerative Medicine by somatic stem cell: the paradigm of epithelial stem cells”, 8 December 2014, Dresden, Germany
  83. XI Hydra Summer School on Stem Cells & Regenerative Medicine, 7-14 September 2014, Hydra, Greece
  84. Università di Catania, Seminar at Scuola Superiore di Catania, 7 July 2014, Catania, Italy
  85. University of Manchester, Seminar “Regenerative Medicine by somatic stem cell: the paradigm of epithelial stem cells”, 27 February 2014, Manchester, UK
  86. International Centre for Genetic Engineering and Biotechnology (ICGEB), Seminar “Regenerative Medicine by somatic stem cell: the paradigm of epithelial stem cells”, 31 May 2013, Trieste, Italy
  87. Università degli Studi di Catania, Seminar “Cellule staminali epiteliali e medicina rigenerativa”, 29 April 2013, Catania, Italy
  88. IRCCS Arcispedale Santa Maria Nuova, Seminario “Dai geni, alle cellule, al paziente: successi clinici dalla ricerca traslazionale”, 7 February 2013, Reggio Emilia, Italy
  89. Università degli Studi di Torino, MBC, Molecular Biotechnology Center, Seminar, 15 January 2013, Torino, Italy
  90. Collegio Cairoli, Seminar “Terapia personalizzata con le cellule staminali: la medicina del futuro”, 25 October 2012, Pavia, Italy
  91. ISMETT, Seminar “Cellule staminali epiteliali e medicina rigenerativa”, 22 October 2012, Palermo, Italy
  92. EuroSyStem, Summer School: Stem Cells & Regenerative Medicine, 15-22 September 2012, Hydra, Greece
  93. Stem Cell Research Institute Leuven, Seminar “Regenerative Medicine by somatic stem cell: the paradigm of epithelial stem cells”, 19 March 2012 Leuven, Belgium
  94. University of Zurich, Institute of Anatomy, Seminar “Regenerative Medicine by somatic stem cell: the paradigm of epithelial stem cells”, 12 March 2012, Zurich, Switzerland
  95. University of Jordan, Seminar, 16 January 2012, Amman, Jordan
  96. Scottish Centre for Regenerative Medicine, Seminar “Epithelial Stem Cells and regenerative Medicine”, 19 December 2011, Edinburgh, UK
  97. Università di Milano, Seminar, 11 November 2011, Milano, Italy
  98. EuroSyStem, Summer School: Stem Cells & Regenerative Medicine, 18-23 September 2011, Hydra, Greece
  99. Institute for Stem Cell Biology & Regenerative Medicine, InStem Frontier Seminar Series, “Epithelial Stem Cell and Regenerative Medicine”, 5-7 September 2011, Bangalore, India
  100. International Centre for Genetic Engineering and Biotechnology (ICGEB), Seminar ” Cellule staminali epiteliali in medicina rigenerativa”, 13 July 2011, Trieste, Italy
  101. SIBBM Seminar Frontiers in Molecular Biology, 26 May 2011, Trieste
  102. Seminario, Università di Catania, 23 May 2011, Catania
  103. Miltenyi Biotec, Symposium “Regenerative medicine and stem cell research, a challenge for the present”, 3 May 2011, Bologna, Italy
  104. BioRep, Incontro “Staminali: e adesso? Ricerca, applicazioni, cure: le nuove frontiere della terapia cellulare”,19 April 2011, Bologna, Italy
  105. Consorzio Italbiotec, “Formazione di ricercatori altamente qualificati nel settore delle Banche di Materiale Biologico per la ricerca, la diagnostica e la clinica”, 12 January 2011, Milano, Italy
  106. Hannover Medical School, Seminar “Epithelial Stem Cells and Regenerative Medicine”, 18 November 2010, Hannover, Germany
  107. National Institutes of Health (NIH), “Epithelial Stem Cell & regenerative Medicine”, 18 October 2010, Bethesda, USA
  108. Stem Cell Summer School for Clinicians, 12-16 July 2010, Cambridge, UK
  109. Università di Catania, Seminar, 6 May 2010, Catania, Italy
  110. Università di Milano-Bicocca, Seminar “Epithelial stem cells and regenerative medicine”, PhD course on Stem Cells, 28 April 2010, Milano, Italy
  111. Università di Napoli, Seminar, 20 April 2010, Napoli, Italy
  112. Università di Napoli, Seminar “Human epithelial stem cells and regenerative medicine”, 1 February 2010, Napoli, Italy
  113. 175th Anniversary, Manchester Medical Society, Telford Memorial Lecture, 27 January 2010, Manchester, UK
  114. Stanford University, Seminar “Human epithelial stem cells and regenerative medicine”, 13 November 2009, Stanford, USA
  115. Università di Milano, Seminar, 4 November 2009, Milano, Italy
  116. EuroSyStem, Summer School: Stem Cells & Regenerative Medicine, 19-25 September 2009, Hydra, Greece
  117. Università di Trieste, Seminar, 2 September 2009, Trieste, Italy
  118. Accademia Nazionale dei Lincei, Seminar “La rigenerazione dei tessuti con le cellule staminali epiteliali”, 26 February 2009, Roma, Italy
  119. Centro Biotecnologie Avanzate (CBA), “Cellule staminali epiteliali in medicina rigenerativa”, 6 November 2008, Genova, Italy
  120. Max Planck Institute of Molecular Cell Biology and Genetics, Seminar, 3 November 2008, Dresda, Germany
  121. V Curso de Quemados, 21-22 May 1992, Madrid, Spain
  122. Advanced Course on “Cell differentiation and death”, Ettore Majorana Centre for Scientific Culture, 6-11 May 1992, Erice (TP), Italy
  123. Workshop on Biotechonolgies in Medicine: “Tissue Engineering”, October 1990, Roma, Italy
  124. First European Course on Biomaterials Reconstructive Surgery, September 1990, Venezia, Italy
  125. Mini-symposium on Keratinocyte interactions, grafting and graft rejections, AZL University of Leiden, January 1990, Leiden, Holland

INTERNATIONAL MEETINGS (Invited speaker)

  1. Gordon Research Conference in Epithelial Differentiation and Keratinization, 4-9 June 2023, Castelldefels, Spain
  2. GRC, Gordon Research Conference on Stem Cells and Cancer, 14-19 May 2023, Lucca
  3. Virtual Epithelial GRC Meeting, 3 April 2023 (remote)
  4. TERMIS 2020, 27-30 March 2023, Manchester, UK
  5. EMBO Regeneration, 26-30 September 2022, Barcelona, Spain
  6. ISSCR/ASGCT 2022 Madison Symposium, “Emerging Therapies at the Intersection of Genetic and Cellular Technologies”, 22-23 September 2022 (remote)
  7. Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, 19th European Burns Association Congress (EBA), 7-10 September 2022, Torino, Italy
  8. Mendel Genetics Conference 2022, 20-23 July 2022, Brno, Czech Republic
  9. The Francis Crick Institute/UCL, Conference on “Stemness, Regeneration and Immunity: from development to therapy”, 20-21 June 2022, London, UK
  10. SkinTERM Annual Meeting 2022, 26-27 March 2022 (remote)
  11. ISSCR Shanghai International Symposium, 12-14 January 2022, Shanghai, China (remote)
  12. 2021 Virtual Ottawa “Till & McCulloch Meeting” (TMM), November 15-17, 2021 (remote)
  13. XIX Meeting of the Spanish Society of Cell Biology, 29 October 2021, Boadilla de Monte, Madrid, Spain
  14. National Foundation for Ectodermal Dysplasias, NFED 2021 Research Conference, October 21-24, 2021 (remote)
  15. IDSB, International Society of Developmental Biology Meeting, 17-21 October 2021, Algarve, Portugal
  16. 14th World Congress of Paediatric Dermatology, 22-25 September 2021, Edinburgh, UK
  17. Nano-Innovation 2021, 22 September 2021 (remote)
  18. DEBRA International Congress 2021, 16-19 September 2021 (remote)
  19. EIC-ERC workshop on Gene and Cell Therapy, 29 June 2021, Online
  20. The European Laboratory Research & Innovation Group, ELRIG Conference “Cell and Gene Therapy 2020”, 18 May 2021 (remote)
  21. American Society of Gene & Cell Therapy, ASGCT 24th Annual Meeting, Scientific Symposium entitled “International Focus on Stem Cell Gene Therapy”, May 13, 2021 (remote)
  22. NCS-Reconstruct 2021 Annual Meeting, May 12, 2021 (remote)
  23. EMBO Regeneration, 7-11 April 2021, Barcelona, Spain
  24. Cellular and Molecular Mechanisms of Tissue Regeneration Meeting, 14-17 February 2021, Bangalore, India
  25. UCL GOS Institute of Child Health, III Mini Symposium on Skin Diseases and Therapies, 4 February 2021 (remote)
  26. SSCN, BCPM and SCRM/TCBM, Key Meeting on “Innovation in Clinical Bio-manufacturing”, 11 December 2020, Bern, Switzerland – TO BE RESCHEDULED
  27. European Wound Management Association, EWMA 2020 Conference, 13-15 May 2020, London, UK – TO BE RESCHEDULED
  28. AstraZeneca R&D Site, Conference on Cell and Gene Therapy, 6-7 May 2020, Gothenburg, Sweden – CANCELLED
  29. ISSCR Shanghai International Symposium, 13-15 March 2020, Shanghai, China – CANCELLED
  30. EMBL Conference: Advances in Stem cells and regenerative Medicine, 8-11 March 2020, Heidelberg, Germany – CANCELLED
  31. Science for Democracy, VI World Congress for Freedom of Scientific Research, 25-26 February 2020, Addis Ababa, Ethiopia
  32. Nature Conference on Advanced Cell Therapies and Tissue Engineering, 14-16 November 2019, Milano
  33. Oxford Stem Cell Institute, Celebratory Lecture “Sir Richard Gardner”, 1 November 2018, Oxford, UK
  34. EMBO, Basel Life: Showcasing Europe’s Excellence in Life Sciences, 9-12 September 2019, Basilea (Svizzera)
  35. Nature Conference “Translating Gene and Cell Therapies”, 6-8 September 2019, Guangzhou, China
  36. Gordon Research Conference in Epithelial Differentiation and Keratinization, 7-12 July 2019, Sunday River, Newry, ME, USA
  37. University College London (UCL), International Opening Symposium of Zayed Centre for research into rare Diseases in Children, 4 July 2019, London, UK
  38. British Society for Gene and Cell Therapy (BSGCT), Annual Conference, 19-21 June 2019, Sheffield, UK*
  39. ESHG, European Human Genetics Conference, 15-18 June 2019, Gothenburg, Sweden*
  40. Pearl Seiden Symposium in Tissue Engineering and Regenerative Medicine: Advances in Stem cell research and 3D Bioprinting, 12-13 june 2019, Haifa, Israel*
  41. WODC2019, 24th World Congress of Dermatology, 10-15 June 2019, Milano
  42. University Medical Center Groningen, Dutch Society for Stem Cell Research Meeting, 17 May 2019, Utrecht, The Netherlands
  43. University of Bonn Medical Faculty, Institute of Reconstructive Neurobiology, Kick-Off Meeting of the Stem Cell Network North Rhine Westphalia, 13-14 May 2019, Dusseldorf, Germany
  44. 30th Joint Meeting of the German, Austrian and Swiss Societies of Human/Medical Genetics, 6-8 March 2019, Weimar, Germany*
  45. The New York Academy of Sciences and Takeda Pharmaceutical Company Limited, Frontiers in Regenerative Medicine: 2019 Innovators in Science Award Symposium, 26 April 2019, Fujisawa, Japan
  46. Simposio “Nanoengineering for Mechanobiology (N4M), 4° edizione, 24-27 March 2019, Camogli
  47. Wellcome Trust/MRC Cambridge Stem Cell Institute,  Retreat of the Cambridge Stem Cell Institute, 14-15 March 2019, Cambridge, UK
  48. Cedars-Sinai Medical Center, Symposium “Translation of Stem Cells to the clinic: Challenges and Opportunities”, 2-4 December 2018, Los Angeles, USA
  49. Oxford Stem Cell Institute (OSCI), OxStem Annual Symposium 2018, November 12-13, 2018, Oxford. UK
  50. 2018 Keystone Symposia “From Rare to Care-Discovery, Modeling and Translation of Rare Diseases”, 11-15 November, Vienna, Austria
  51. 9th World Orphan Drug Congress, 6-8 November 2018, Barcellona, Spagna
  52. Belgian Society of Stem Cells Research, Annual Meeting, 26 October 2018, Leuven, Belgio
  53. German Society for Cell Biology, International Meeting, 17-19 September 2018, Lipsia, Germania
  54. GRC, Gordon Research Conference on Tissue Niches & Resident Stem Cells in Adult Epithelia, 19-24 August 2018, Waterville Valley, New Hampshire, USA
  55. Japanese Society of Gene and Cell Therapy, Annual Meeting, 26-28 July 2018, Tokyo, Japan
  56. International Society for Stem Cell Research, 2018 ISSCR Annual Meeting, 20-23 June 2018, Melbourne, Australia
  57. Israel Stem Cell Society, ISCS Annual Meeting, 31 May 2018, Tel Aviv, Israele
  58. Cold Spring Harbor Asia, Stem Cell Crossroads Conference, 7-11 May 2018, Suzhou, Cina
  59. CYTO 2018, 33rd Congress of the International Society for Advancement of Cytometry, 28 April-2 May 2018, Praga, Repubblica Ceca
  60. Stanford University, Academic cGMP Symposium: Cellular Therapeutics & Translational Medicine, 19-20 March 2018, Stanford, USA
  61. DIF, The 4th Annual Dermatology Innovation Forum, 15 February 2018, San Diego, USA
  62. Fondazione Ferrero, International Congress “La Scienza della Longevità/ Invecchiamento di Successo”, 9-12 November 2017, Alba, Italy
  63. iMed Conference 9.0 Lisbon 2017, 27-29 October 2017, Lisbon, Portugal
  64. Campus Berlin-Buch, Symposium “DECHEMA visits Berlin-Buch: Trading in cells – Lab cultures, patients, and the promise of applications”, 18 October 2017, Berlino
  65. ESGCT, XXV Annual Congress, 17-20 October 2017, Berlin, Germany
  66. 66th Annual Montagna Symposium on the Biology of Skin, “Precision Dermatology: Next Generation Prevention, Diagnosis and Treatment”, 12-16 October 2017, Skamania Lodge, Stevenson, WA, USA
  67. DEBRA International, 4th Conference of EB-CLINET, 26-27 September 2017, Salzburg, Austria
  68. DEBRA International, EB2017 – 5th World Conference of EB Research, 24-27 September 2017, Salzburg, Austria
  69. ABCD 2017 Meeting,  The Biennial Congress of the Italyn Association of Cell Biology and Differentiation, 21-23 September 2017, Bologna
  70. ISSCR, 15th Annual Meeting, 14-17 June 2017, Boston, MA, USA
  71. EMBL, EMBO Conference Series “Advances in Stem Cells and Regenerative Medicine Conference”,  23-26 May 2017, Heidelberg, Germany
  72. Stem cell Network North Rhine Westphalia, The 9th International Meeting of the Stem Cell Network North Rhine Westphalia, 16-17 May 2017, Münster, Germany
  73. Advances in Stem Cell Research Conference, 8-10 May 2017, Amsterdam, The Nederlands
  74. Labex Revive Annual Meeting,  23-25 January 2017, Paris, France
  75. Austrian Society of Dermatology and Venereology (ÖGDV), Science Days, 13-14 January 2017, Fuschl, Austria
  76. German Centre for Cardiovascular Research (DZHL),  DZHL 1st International Meeting on Translational Medicine, 11-12 January 2017, Berlin, Germany
  77. Institut Pasteur, 1st French Society for Stem Cell Research Meeting, 7 November 2016, Paris, France
  78. Royan Institute for Stem Cell Biology and Technology, 12th international Congress on Stem Cell Biology and Technology, 31 August-2 September 2016, Tehran, Iran
  79. Gordon Research Conference 2016, “Tissue Niches & Resident Stem Cells in Adult Epithelia”, 7-12 August 2016, Hong Kong, China
  80. The Tamil Nadu Ophtalmic Association, 64th Annual TNOA Conference, 5-7 August 2016, Vellore, India
  81. Christian Medical College, Centre for Stem Cell Research, 1st Annual Symposium on Cell and Gene Therapy, 5-6 August 2016, Vellore, India
  82. BC Cancer Agency, 2015 Till and McCulloch Meeting, 26-28 October 2015, Toronto, Canada
  83. Interuniversity Institute of Miology, XII Annual Meeting, 1-4 October 2015, Reggio Emilia
  84. ICGEB, “Molecular mechanisms in tissue degeneration and regeneration”, 1-3 October 2015, Buenos Aires, Argentina
  85. EMBO Conference “Cell therapy today: achievements, hopes and hypes”, 9-13 September 2015, Manchester, UK
  86. Cornell University, 5th Stem Cell Symposium, 13 June 2015, Ithaca, New York, USA
  87. Qatar Biobank, “Biobanking and Personalized Healthcare” Conference, 8-9 February 2015, Doha, Qatar
  88. Italian Embassy London, “Development Pathways for Advanced Therapy Medicinal Products” Workshop, 15 December 2014, London, UK
  89. Swiss Institute of Cell Therapies, 2nd SICT Scientific Meeting “Translational research and expertise in field of Regenerative with a particular focus on regulatory aspects”, 12 November 2014, Geneva, Switzerland
  90. The New York Stem Cell Foundation, Ninth Annual Translational Stem Cell Conference, 22-23 October 2014, New York, USA
  91. Translational Centre for Regenerative Medicine, University of Leipzig, “Translational Regenerative Medicine, 21-22 October 2014, Leipzig, Germany
  92. Bridging Biomedical Worlds conference “Turning Obstacles into Opportunities for Stem Cell Therapy”, 13-15 October 2014, Beijing, China
  93. ESAO, 41st Annual Meeting, 17-20 September 2014, Roma
  94. 5th International Regenerative Medicine Symposium, 26-27 June 2014, Luebeck, Germany
  95. ISSCR, 12th Annual Meeting, 18-21 June 2014, Vancouver, Canada
  96. International Parkinson and Movement Disorder Society, 18th International Congress of Parkinson’s Disease and Movement Disorders, 8-12 June 2014, Stockholm, Sweden
  97. ESHG, European Human Genetics Conference 2014, 31 May-3 June, 2014, Milano
  98. Stem Cell Research Italy Meeting, 28-30 May 2014, Salerno
  99. ASGCT, 17th Annual Meeting, 21-24 May 2014, Washington DC, USA
  100. University of Edinburgh, “Stem Cells and Regenerative Medicine: Current Status and Future Prospects” meeting, 1-2 May 2014, Edinburgh, UK
  101. Fondazione IBSA, Workshop “Stem cells therapy: hype or hope?”, 29 March 2014, Lugano, Switzerland
  102. Consorzio Ferrara Ricerche, 2014 International Meeting on Asthma Copd and Concomitant Disorders, 6-8 March 2014, Modena
  103. German Stem Cell Network, 1st Annual Meeting, 11-13 November 2013, Berlin, Germany
  104. World Conference on Regenerative Medicine, 23-25 October 2013, Leipzig, Germany
  105. ISSCR, Regional Forum Series 2013, “Stem Cells in Translation, 15-18 September 2013, Firenze
  106. ISN Forefronts Symposium 2013 “Stem Cells and Kidney Regeneration”, 12-15 September 2013, Firenze
  107. Basel Postdoc Network Retreat 2013, 22-24 July 2013, Arosa, Svizzera
  108. Stem Cell Research Italy, 27-29 June 2013, Brescia
  109. 1st International Congress of the Jordanian Optometric Society, 23-25 May 2013, Amman, Jordan
  110. European Parliament Information Office in the UK, “Revision of EU Clinical Trials Directive”, 22 February 2013, London, UK
  111. American Society of Hematology, 54th Annual Meeting, 8-11 December 2012, Atlanta, GA, USA
  112. 7th Fraunhofer Life Science Symposium, 29-30 November 2012, Leipzig, Germany
  113. German Society for Cell Biology, International Meeting on “Molecular Concepts in epithelial differentiation, pathogenesis and repair”, 7-10 November 2012, Leipzig, Germany
  114. Stem Cell Meeting on the Mesa VII, 29-31 October 2012, La Jolla, CA, USA
  115. 1st Conference of EB-CLINET, 5-7 October 2012, Salzburg, Austria
  116. International Society of Burn Injuries, International Symposium on “Advances in Burn Care through Stem Cell Research”, 9-13 September 2012, Edinburgh, UK
  117. The Swiss Society for Anatomy, Histology, and Embryology Annual Meeting, 7 September 2012, Zurich, Switzerland
  118. Andalusian Initiative for Advanced Therapies, 1st International Symposium on Cell and Gene-Based Therapies, 28-29 June 2012, Granada, Spain
  119. Stem Cell Research Italy & International Society For Cellular Therapy-Europe AICC, Joint Meeting, 20-21 June 2012, Ferrara
  120. 15th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), 16-19 May 2012, Philadelphia, PA, USA
  121. Keystone Symposium “Mechanism of Whole Organ Regeneration” and “Regenerative Tissue Engineering and Transplantation”, 1-6 April 2012, Breckenridge, CO, USA
  122. International Congress on Research of Rare and Orphan Diseases, 29 February–2 March 2012, Basel, Switzerland
  123. III International Conference on Regenerative Surgery, 14-16 December 2011, Roma
  124. World Conference on Regenerative Medicine, 2-4 November 2011, Leipzig, Germany
  125. IV International Nanotechnology Forum (Rusnanotech 2011), 26-28 October 2011, Moscow, Russia
  126. 60th Montagna Symposium on the Biology of the Skin, Columbia River Gorge, 13-17 October 2011, Stevenson, WA, USA
  127. ISSCR, 9th Annual Meeting of the International Society of Stem Cell Research, 15-18 June 2011, Toronto, Canada
  128. Gordon Research Conference 2011 Tissue Repair & Regeneration, 5-10 June 2011, New London, NH, USA
  129. EMBO Conference: Advances in Stem Cell Research: Development, Regeneration and Disease, 6-8 April 2011, Paris, France
  130. 2nd Cardiac and Pulmonary Regeneration Meeting, European Association for Cardio-Thoracic Surgery (EACTS), 3-4 December 2010, Wien, Austria
  131. 22nd Pasteur-Weizmann Symposium “Stem Cells – From Basic Biology to Clinical Therapies”, 7-9 June 2010, Roma
  132. 54th  Nobel Conference “Nobel Conference on Regenerative Medicine” Nobel Forum, Karolinska Institutet, 13-16 April 2010, Stockholm, Sweden
  133. 175th Anniversary, Manchester Medical Society, Telford Memorial Lecture,Manchester, UK, 27 January  2010
  134. 2nd International Congress on Responsible Stem Cell research (RSCR), “Adult somatic stem cells: new perspective”, 26-28 November 2009, Monaco, Principato di Monaco
  135. 22nd IGB Meeting “Stem Cells: From Molecular Physiology to Therapeutic Applications”, 10-13 October 2009, Capri
  136. Gordon Research Conferences, “Epithelial Differentiation and Keratinization”, 21-26 June 2009, Les Diablerets, Switzerland
  137. JIM Symposium ”Regenerative Medicine – From Stem Cells to the Clinic”, 12-13 March 2009, Nobel Forum, Karolinska Institutet, Stockholm, Sweden
  138. International Conference “Recent Advances in Biotherapeutics, 13-14 February 2009, Bombay, India
  139. Annual Meeting of the European Dermatology Forum (EDF), 23-24 January 2009, Interlaken, Switzerland
  140. XIX Reunion Clinica Internacional de Dermatologia, 29 February-1 March 2008, Barcelona, Spain
  141. International meeting on “Stem cells in tissue homeostasis, repair and cell therapy”, 28-30 May 2008, Roma
  142. 2nd International Congress on Stem Cells and Tissue Formation, 6-9 July 2008, Dresden, Germany
  143. DEBRA Congres International, 1-4 November 2007, Avignon, France
  144. 1st Helvetic Course on Pediatric Dermatology, 30-31 August 2007, Lausanne, Switzerland
  145. Gordon Research Conferences, “Epithelial Differentiation and Keratinization”, 29 July-3 August 2007, Smithfield, RI, USA
  146. International Society of Stem Cell Research (ISSRC), 5th Annual Meeting, 17-20 June 2007, Cairns, Queensland, Australia
  147. Keynote Lecturer at the 16th European Academy of Dermatology and Venereology (EADV), 16-20 May 2007, Vienna, Austria
  148. Keynote Lecturer at the 5th Annual Meeting of the Canadian Stem Cell Network, , 13-15  November 2006, Ottawa, Canada
  149. International Symposium on “Science and Technology of Skin”, 15-18 October 2006, Shanghai, China
  150. EMEA Workshop on “Working Party on cell-based products”, 21-22 June 2006, London, UK
  151. 2nd Boden Conference on Skin Biology, 22-26 September 2006, Stradbroke Island, Australia
  152. Joint Annual Meeting of the Austrian Biochemistry/Molecularbiology Associations, 25-27 September 2006, Salzburg, Austria
  153. International Meeting on Advances in Stem Cell Research, 8-10 September 2006, Lausanne, Switzerland
  154. 1st International Conference for Ocular Cell Biology, 6-10 September 2006, Cambridge, UK
  155. Keystone Symposium “Stem Cells”,Whistler, 27 March-1 April 2006, British Columbia, Canada
  156. EuroStemCell Workshop on Current Clinical Applications of Stem Cells, in association with the Academy of Medical Sciences, 20 March 2006, London, UK
  157. UK Cornea Society, 8th Annual Meeting of the, 17 March 2006, Newcastle upon Tyne, UK
  158. European Eye Bank Association (EEBA), XVIII Annual Meeting of the, 20-21 January 2006, Venezia
  159. International symposium on “Stem cells in the third millenium: current and future medical applications”, 16 November 2005, Napoli
  160. 15th International Conference on Laboratory Medicine and 12th European Conference on Clinical Molecular Biology, 11-12 November 2005, Napoli
  161. International conference of the ERGOB “Facing the future – challenges in oral biology”, 1-4 September 2005, Geneva, Switzerland
  162. Gordon Research Conferences, “Epithelial Differentiation and Keratinization”, Chairman Issue Rising Session, 29 May-3 June 2005, Il Ciocco, Lucca, Italy
  163. Timberline Symposium: “Keratinocyte stem cells: tissue regeneration, wound repair, and environmental responses”, 5-8 February 2005, Timberline Lodge, Mount Hood, Oregon, USA
  164. 8th Meeting of the European Dermatology Forum, 21-22 January 2005, Interlaken, Switzerland
  165. 13th Congress of EADV European Academy of Dermatology, 17-21 November 2004, Firenze
  166. Internation symposium on “Talking with stem cell differentiating agents: a novel approach to the rescue of injured tissues”, Bologna, Italy, 21-22 June 2004
  167. International symposium on “Keratinocyte proliferation and differentation in the epidermis”, Bonner Forum Biomedicine, Bonn, Germany, 24-25 May 2004
  168. International Meeting on “Adult Stem Cells: A Challenge for the Future”., Bologna, Italy, 21-23 March 2004
  169. International Conference “Towards clinical gene therapy: pre-clinical assessment of gene transfer”, Ballaterra (Barcelona), Spain, 1-5 February 2004
  170. International Workshop “From Stem Cell Biology to Cell and Gene Therapy Applications”. Abano Terme, (PD), Italy, 6-8 October 2003
  171. International symposium on “New directions in tissue repair and regeneration”, Royal Society, London, England, 24-25 September 2003
  172. 13th Annual Meeting of the European Tissue Repair Society, Amsterdam, Holland, 21-23 September 2003
  173. 2nd Annual Meeting of the European Tissue Engineering Society, ETES, Genova, Italy, 3-6 September 2003
  174. 27th Annual Meeting of the Japan Cornea Society and 19th Annual Meeting of the Japanese Corneal Transplantation Society, Karuizawa, Japan, 19-22 February 2003
  175. 5th International Meeting of the Tissue Enginnering Society, Kobe, Japan, 8-10 December 2002
  176. 32th International Meeting of the ESDR Society, Geneve, Switzerland, 18-20 September 2002
  177. XIXth Journee Jean-Claude Dreyfus: Stem cells: Differentiation and Plasticity, Paris, France, 13 September 2002
  178. 20th World Congress of Dermatology, Paris, France, 1-5 July 2002
  179. XXth meeting of the European Society of Human Genetics, Strasbourg, France, 25-28 May 2002
  180. Bioeurope 2002, European Conference on Gene Therapy and Vaccines, Roma, Italy , 23-25 May 2002
  181. First Scandinavian conference on Epidermolysis Bullosa, Oslo, Norway, 21-23 April 2002
  182. Timberline Symposium: “Embryogenesis, Growth, and Differentiation of Epithelial Tissues”, Timberline Lodge, Mount Hood, Oregon, USA , 2-5 February  2002
  183. International Symposium “The Stem Cell Dilemma”, Ateneo Pontificio Regina Apostolorum, Roma, Italy, 13-14 November 2001
  184. 1st Biennial Meeting of the European Tissue Engineering Society (ETES), Freiburg, Germany, 7-10 November 2001
  185. International symposium on “Keratinocyte proliferation and differentation in the epidermis”, Bonner Forum Biomedicine, Bonn, Germany, 5-6 October 2001
  186. 10th International Symposium on Basement Membranes, Salzburg, Austria, 27-29 September 2001
  187. 31th International Meeting of the ESDR Society, ESDR satellite symposium on: “Cutaneous gene therapy: applications in genodermatoses and wound healing”, Uppsala, Sweden, 18-20 September 2001
  188. 4th Annual Meeting of the Japanese Society of Tissue Engineering, Tokyo, Japan, 6-9 July 2001
  189. Annual Meeting of the Sociedad Argentina de Dermatologia (SAD), Buenos Aires, Argentina, 8-9 June 2001
  190. International Symposium on “Therapeutic applications of human stem and precursor cells”, Hannover, Germany, 2-3 November 2000
  191. 20th EADV Meeting, Geneve, Switzerland, 11-14 October 2000
  192. 8th Meeting of the European Society of Gene Therapy (ESTG), Stockholm, Sweden, 7-10 October 2000
  193. 4th European Biotechnology Symposium, Amsterdam, The Netherlands, 17-19 September 2000
  194. International workshop “Tissue Engineering and Cellular Cultures”, Villa Gualino, Torino, 29-30 May 2000
  195. “TEBIO 2000” International Meeting and Exhibition, Genova, Italy, 24-26 May 2000
  196. ARVO Meeting, Ft. Lauderdale, FL, USA, 30 April-5 May 2000
  197. First International Conference on “Cutaneous gene therapy: problems and prospects”, NIH, Bethesda, MD, USA, 23-24 April 2000
  198. Bonner Forum Biomedicine, Bonn, Germany, 26-27 February 2000.
  199. 2nd BioValley Tissue Engineering Symposium. Freiburg, Germany, 25-27 November 1999
  200. International Workshop on Basement Membranes. Nice, France, 14-16 November 1999
  201. 8th Convention TELETHON, Rimini (RN), Italy, 14-16 November 1999
  202. International Workshop of the German Society for Cell Biology: “Defined cell cultures: from basic research to clinical application”. Heidelberg, Germany, 9-10 October 1999
  203. 29th International Meeting of the ESDR Society. Montpellier, France, 22-25 September 1999
  204. International meeting of ETCS – STCS. Ginevra, Switzerland, 31 August-03 September 1999
  205. World Congress of Criobiology, Marseille, France, 12-15 July 1999
  206. 16th ESACT Meeting, Lugano, Switzerland, 25-29 April 1999
  207.  International workshop “Vitiligo: where do we stand?”, Roma, Italy, 28 January 1999.
  208. GZG-ETCS  International Workshop on “Principles and Perspectives of Tissue Engineering for basic and applied research”, Hannover, Germany, 15-17 October 1998
  209. International Symposium on “Cell growth, differentiation and transformation: a tribute to Howard Green”, Boston, USA, 2-3 October 1998
  210. Congresso Internazionale di Dermatologia Neonatale, Bari, Italy, 24-27 September1998
  211. European conference on “Tissue and Cell Engineering”, Santa Margherita Ligure (GE), Italy, 18-23 September 1998.
  212. Satellite Symposium of the International Investigative Dermatology (IID) “Disorders of Keratinization – A Molecular Perspective”, 4-5 May1998, Kloster Walberberg, Bornheim, Germany
  213. 27th Annual Meeting of the European Society for Dermatology, 4-7 October 1997, Roma
  214. Annual Meeting of the British Burn Association, 5-17 April 1998, Sheffield, UK
  215. Congresso Internazionale Interdisciplinare clinico-biologico: “Clinical applications of cultured human epidermis”, 3 October1997, Roma
  216. 19th World Congress of Dermatology, “Keratinocytes Biology Workshop”, 15-21 June 1997, Sidney, Australia
  217. 42nd International Congress of European Tissue Culture Society (ETCS), 12-15 October 1997, Mainz, Germany
  218. First Nordic HUGO Workshop on Gene Therapy, 30 May-1 June 1997, Aarhus, Denmark
  219. Guest speaker at the Annual Meeting of the British Society for Investigative Dermatology, , 10-11 April 1997, Bristol, England
  220. Fifth Cryobiology Congress, 20-23 November 1996, Oviedo, Spain
  221. Annual Scientific Meeting of the Rene Tourain Foundation, 25 October1996, ????
  222. ESH European School of Haematology “Stem cells and gene transfer into stem cells”, 27-30 April 1996, Palermo
  223. Second Ocular Surface and Tear Workshop (ARVO satellite meeting), 20 April 1996, Miami, FL, USA
  224. Fourth Cryobiology Congress, 1-4 November 1995, Oviedo, Spain
  225. Gordon Research Conferences, “Epithelial Differentiation and Keratinization”, 16-21 July 1995, Tilton, NH, USA
  226. Third Cryobiology Congress, 18-21 November 1994, Oviedo, Spain
  227. International Symposium of Plastic Surgery and Burns, 25-27 May 1994, Brno, Czech Republic
  228. XXIX Congress of the European Society for Surgical Research Surgery Engeneering Synergy, 17-20 May 1994, Montpellier, France
  229. Annual Meeting of the Japanese Dermatological Association, 20-23 April 1994, Fukuoka, Kyushu, Japan
  230. Joint Meeting of the Wound Healing Society and the European Tissue Repair Society, 22-25 August 1993, Amsterdam, Holland
  231. Eight Annual Meeting of the European Cytoskeletal Forum, 12-15 September 1993, Assisi (PG)
  232. International Symposium on Reconstructive Pelvic Surgery, 18-20 February 1993, Mainz, Germany
  233. First Cryobiology Congress, 18-21 November 1992, Oviedo, Spain
  234. International Symposium “In vitro systems for studying epithelial and endothelial transport and metabolism: applications in pharmacology and toxicology”, 13 October 1992, Gerenzano (VA)
  235. University of Bristol Biotechnology Symposium “New clinical and scientific materials from new biology”, 7 October 1992, Bristol, UK
  236. Workshop on “Culture of human epithelial cells”, September 1992, Buenos Aires, Argentina
  237. 18th World Congress Of Dermatology, 12-18 June 1992, New York, USA
  238. First Congress of the European Academy of Dermatology and Venereology, September1989, Firenze
  239. 40th Annual Meeting of the Tissue Culture Association, June 1989, Orlando, FL, USA
  240. Harvard Medical School, “Cultured Epithelial Grafts in Wound Closure”, April 1989, New Orleans, USA
  241. COMAC-BME Workshop (CEE), March 1989, Lyon, France
  242. Workshop on Biotechnologies in Medicine, November 1988, Portofino (GE)
  243. Convention on Biotechnologies in Medicine, Biochemistry Enviroment Agriculture and Zoology, October 1988, Torino
  244. International Symposium on Grafts and Transplantation, June 1987, Marseille, France

SCIENTIFIC DISSEMINATION

SCIENCE POPULARIZATION EVENTS
  1. Accademia Medica di Roma, Conferenza AMR, 16 March 2023, Rome, Italy
  2. Comune di Casina, I martedì della cantoniera, 2 August 2022, Casina (RE), Italy
  3. Le ali di Camilla, EB Day, 21 May 2022, Modena, Italy
  4. Festa della Scienza, XIII Edition, 12-14 May 2022, Salento, Italy
  5. XI edizione Festa di Scienza e di Filosofia-Virtute e Canoscenza, “Riprendiamo il cammino. La Scienza. Il nuovo sviluppo. Il libero pensiero”, 21-24 April 2022, Foligno (PG)
  6. Associazione Luca Coscioni, Progetto “ScolarMente” – La ricerca sulle Cellule Staminali, 11 March 2022 (remote)
  7. Rare Disease Day, RaccontRare 2.0: L’Epidermolisi Bollosa a Modena dalla diagnosi alla terapia genica, 21 February 2022 (remote)
  8. Scienza: Ultima Frontiera a Brugherio, Edizione 2021, 5 November 2021, Brugherio (MI)
  9. Rare Disease Day, RaccontRare: l’Epidermolisi Bollosa dalla voce di pazienti, ricercatori e clinici, Modena, 28 February 2021 (remote)
  10. National Geographic, Festival delle Scienze, 23-29 November 2020, Roma
  11. I martedì alla Cantoniera, 21 July 2020, Casina (RE), Italy
  12. Fondazione Cassa di Risparmio di Modena, “Into the Future” lezione agli studenti dell’Istituto Leonardo Da Vinci e del Liceo Formiggini, 11 February 2020, Modena
  13. Fondazione Ferrero, 11 December 2019, Alba, Cuneo, Italy
  14. Liceo Scientifico Cocito, 11 December 2019, Alba, Cuneo, Italy
  15. Biblioteca Delfini, Mese della Scienza, “Cellule che curano”, 30 November 2019, Modena
  16. Focus Live 2019, “Geni e cellule: le terapie del futuro. La rivoluzione biomedica raccontata dai suoi protagonisti”, 23 November 2019, Milano, Italy
  17. Le ali di Camilla, Serata di presentazione dell’associazione, 26 October 2019, Modena, Italy
  18. UniStem Tour, 22 October 2019, Napoli
  19. Unimore, “Università e cittadini, relazioni virtuose. La funzione del Public Engagement”, 16 October 2019, Modena, Italy
  20. European Biotech Week ad Emilia-Romagna Open, Incontro con i Consiglieri Comunali di Modena, 27 September 2019, Modena, Italy
  21. Modena Smart Life, “Doctor web”, 27 September 2019, Modena
  22. Festa de L’Unità, “Cellule staminali tra scienza e pseudoscienza”, 29 August 2019, Modena, Italy
  23. I martedì alla Cantoniera, 30 July 2019, Casina (RE), Italy
  24. Festival della Scienza Medica, 9-12 May 2019, Bologna, Italy
  25. Accademia Nazionale di Scienze, Lettere e Arti di Modena, “Democrazia e Competenza Scientifica”, 11 April 2019, Modena, Italy
  26. DEBRA Südtirol–Alto Adige, Meeting annuale, 6-7 April 2019, Dobbiaco (BZ), Italy
  27. Unistem, XI edizione della Giornata della Scienza dedicata alle scuole superiori, 15 March 2019, Modena, Stefania Bettinelli, Elena Enzo, Eustachio Attico, Laura De Rosa, Davide Adamo, Michael Giovanardi
  28. Rotary Club Casalmaggiore Viadana Sabbioneta e Rotary Club Casalmaggiore Oglio Po, “Cellule staminali e medicina Rigenerativa tra scienza e pseudoscienza”, 11 March 2019, Casalmaggiore (CR), Italy
  29. “Il Centro di Medicina Rigenerativa ‘Stefano Ferrari’: 10 anni di successi internazionali”, 28 February 2019, Modena, Italy
  30. Istituto Tecnico Grazia Deledda, Lezione, 13 February 2019, Lecce
  31. Giovedì Scienza, “Cellule che curano”, 7 February 2019, Modena, Italy
  32. Caffè Scienza, “Cellule staminali tra scienza, pseudoscienza ed etica”, 27 November 2018, Modena, Italy
  33. Bergamo Scienza, Conferenza “Bambini geneticamente modificati”, 20 October 2018, Bergamo, Italy
  34. Istituto Italiano di Cultura, “Incurable diseases now treated: new challenges for science and ethics”, 12 October 2018, London, UK
  35. “Trieste Science & the City”, 3 October 2018, Trieste, Italy
  36. Festival Filosofia, Lectio magistralis “Ricerca scientifica: il paradigma delle cellule staminali tra laboratorio e società”, 14 September 2018, Modena, Italy
  37. DEBRA Südtirol–Alto Adige, Meeting annuale, 14-15 April 2018, Dobbiaco (BZ), Italy
  38. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Formiggini di Sassuolo (MO), 28 March 2018, Modena
  39. Unistem, X edizione della Giornata della Scienza dedicata alle scuole superiori, 16 March 2016, Modena, Italy
  40. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Paradisi di Vignola (MO), 14 March 2018, Modena
  41. BioMedDay, 6 March 2018, Firenze, Italy
  42. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti degli Istituti Corni e Fermi di Modena, 5 March 2018, Modena
  43. Workshop del progetto POR-FESR “Hologene 7 come modello di sviluppo di una terapia avanzata a base di cellule staminali geneticamente corrette, 3 March 2018, Modena, Italy
  44. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Volta di Sassuolo (MO), 26 February 2018, Modena
  45. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Selmi di Modena, 8 February 2018, Modena
  46. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Leonardo da Vinci di Carpi (MO), 1 February 2018, Modena
  47. Incontro con gli studenti del Liceo Classico Muratori, 25 January 2018, Modena
  48. Incontro con gli ex-alunni dell’Istituto Selmi, 20 January 2018, Modena
  49. Festa provinciale PD, “Con dignità, fino alla fine. Dibattito sul fine vita”, 25 August 2017, Modena, Italy
  50. Collegio Ghislieri, “Sulla libertà di Vivere e Morire – I limiti della legge e il ruolo della società civile”, 5 June 2017, Pavia, Italy
  51. Festival vicino/lontano, 14 May 2017, Udine, Italy
  52. Associazione Luca Coscioni per la libertà di ricerca scientifica, Comune di Orvieto e Centro studi città di Orvieto, SCOLAR-MENTE: divulgazione del metodo scientifico, 29 April 2017, Orvieto, Italy
  53. Festival della Scienza Medica, 20-23 April 2017, Bologna, Italy
  54. ELSA, European Law Students’ Association, Appuntamenti di Biodiritto, “Cellule Staminali: il fiume scientifico e gli argini giuridici”, 10 April 2017, Urbino
  55. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti del Liceo Classico Muratori e del Liceo Classico San Carlo di Modena, 27 March 2017, Modena
  56. DEBRA Südtirol–Alto Adige, Meeting annuale, 25-26 March 2017, Dobbiaco (BZ), Italy
  57. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Cavazzi Sorbelli di Pavullo (MO), 22 March 2017, Modena
  58. Unistem, IX edizione della Giornata della Scienza dedicata alle scuole superiori, 17 March 2017, Modena, Italy
  59. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Selmi di Modena, 14 March 2017, Modena
  60. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Fermi di Modena, 13 March 2017, Modena
  61. Ordine dei Medici di Brescia, Pomeriggi della Medicina, “Cellule della speranza – Le staminali viste con gli occhi della scienza”, 9 March 2017, Brescia, Italy
  62. Giornate della Laicità, incontro con gli studenti del Liceo Scientifico Spallanzani, 4 March 2017, Reggio Emilia
  63. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti dell’Istituto Volta e del Liceo Scientifico di Scienze Applicate di Sassuolo (MO), 2 March 2017, Modena
  64. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti del Liceo Formiggini di Sassuolo (MO), 24 February 2017, Modena
  65. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti del Liceo Classico Muratori, del Liceo Classico San Carlo e del Liceo Scientifico Tassoni di Modena, 8 February 2017, Modena
  66. Fondazione Cassa di Risparmio di Modena, “Into the Future”: Incontro con gli studenti del Liceo Scientifico Tassoni di Modena, 6 February 2017, Modena
  67. LIBERAmente teatro 2016, Cenere con ALTRARTE, 17 December 2016, Gonzaga (MN), Italy
  68. Associazione Luca Coscioni per la libertà di ricerca scientifica, Comune di Orvieto e Centro studi città di Orvieto, SCOLAR-MENTE: divulgazione del metodo scientifico, 17 December 2016, Orvieto, Italy
  69. Meet the Scientist, Rassegna Caffè Scienza, “Cellule staminali: a cosa servono, cosa possono e non possono curare”, 1 December 2016, Modena, Italy
  70. SCOLAR-MENTE: divulgazione del metodo scientifico (Iniziativa in adesione all’evento Notte dei Ricercatori), 24 September 2016, Orvieto, Italy
  71. Festival della Scienza Medica, 19-22 May 2016, Bologna, Italy
  72. DEBRA Südtirol–Alto Adige, Meeting annuale, 9-10 April 2016, Dobbiaco (BZ), Italy
  73. Unistem, VIII edizione della Giornata della Scienza dedicata alle scuole superiori, 11 March 2016, Milano, Italy
  74. Conferenza sulla Libertà di Ricerca Scientifica, 3 March 2016, Belluno
  75. Associazione Luca Coscioni per la libertà di ricerca scientifica, Convegno “L’Italy davanti al giudizio di costituzionalità sul divieto di ricerca sugli embrioni”, 18 February 2016, Roma, Italy
  76. Libera Università Crostolo – Incontri con la Scienza, “Cellule staminali tra scienza, pseudoscienza ed etica”, 9 February 2016, Reggio Emilia, Italy
  77. Caffè Scienza, “Le cellule staminali: cosa sono, a cosa servono, cosa possono e non possono curare”, 27 January 2016, Vignola (MO), Italy
  78. X Edizione Premio “Luigi Coppola – Città di Gallipoli”, 29 October 2015, Gallipoli (LE), Italy
  79. Università degli Studi di Modena e Reggio Emilia, Notte dei ricercatori, 25 September 2015, Modena, Italy
  80. Istituto Italiano di Cultura, Conferenza “Cellule staminali tra scienza, pseudoscienze ed etica”, 17 September  2015, Vilnius, Lituania
  81. Festival della Scienza Medica, “Cellule staminali tra scienza e pseudoscienza”, 10 May 2015, Bologna, Italy
  82. Associazione Iniziativa Laica, Giornate della Laicità, “Dialogo tra Michele De Luca e Gilberto Corbellini. Cellule staminali embrionali in medicina rigenerativa e riproduttiva tra scienza e bioetica”, 18 April 2015, Reggio Emilia, Italy
  83. “Dalla ricerca sulle staminali alla ‘fabbrica’ dei nuovi farmaci”, 10 April 2015, Modena, Italy
  84. Consiglio Comunale, Cerimonia di consegna di consegna della Bonissima al CMR e ad Holostem, 9 April 2015, Modena, Italy
  85. Associazione Luca Coscioni per la libertà di ricerca scientifica, Convegno “2004-2015 Legge 40/04 Staminali e fecondazione assistita: evoluzione giurisprudenziale dei diritti della persona”, Senato, 8 April 2015, Roma, Italy
  86. Settimana della Scienza, Incontro con i ragazzi delle scuole superiori, 16 March 2015, Gallarate (VA), Italy
  87. La medicina rigenerativa con cellule staminali tra mito e realtà: conversazione con il prof. Michele De Luca, 15 March 2015, Besnate (VA), Italy
  88. Debra SudTirol, Meeting annuale, 14-15 March 2015, Dobbiaco (BZ), Italy
  89. Unistem, VII edizione della Giornata della Scienza dedicata alle scuole superiori, 13 March 2015, Modena, Italy
  90. Manifattura delle idee, “Tecnopoli e Hub di Innovazione: strategie per rilanciare imprese e opportunità”, 19 February 2015, Modena, Italy
  91. Accademia dei Concordi, Ciclo di lezioni dedicate alla ricerca biomedica: “Staminali adulte e terapia cellulare”, 31 January 2015, Rovigo, Italy
  92. Ospedale M. Bufalini, Convegno “Le banche dei tessuti e delle cellule nel Sistema Sanitario Nazionale: esperienze in regione Emilia Romagna”, 4 October 2014, Cesena, Italy
  93. Festival della Salute, La biomedicina incontra l’etica: un dibattito proficuo per il cittadino consapevole, 25-26 September 2014, Viareggio, Italy
  94. Festa de l’Unità provinciale di Modena, “Caso Stamina: tra compassione, comunicazione, scienza e… truffa”, 4 September 2014, Modena, Italy
  95. Cerimonia di consegna del Premio Giorgio Ambrosoli all’integrità, responsabilità e professionalità, 30 June 2014, Milano, Italy
  96. Comune di Padova, Premio letterario per la divulgazione scientifica Galileo, 9 May 2014, Padova, Italy
  97. Accademia Nazionale di Scienze, Lettere e Arti di Modena, Conferenza “Curare con le cellule staminali: realtà o illusione?”, 23 April 2014, Modena, Italy
  98. Associazione Iniziativa Laica, Giornate della Laicità, “Dialogo tra Michele De Luca e Maurizio Mori”, 12 April 2014, Reggio Emilia, , Italy
  99. Congresso Mondiale per la Libertà di Ricerca Scientifica, 4-6 April 2014, Roma, Italy
  100. Debra SudTirol, Meeting annuale, 4-6 April 2014, Dobbiaco (BZ), Italy
  101. Incontro con gli studenti del Liceo Classico L. A. Muratori, 25 March 2014, Modena, Italy
  102. UniStem, VI edizione della Giornata della Scienza dedicata alle scuole superiori, 14 March 2014, Modena, Italy
  103. AMMI,”Le Terapie Cellulari Avanzate”, 4-5 October 2013, Milano, Italy
  104. Convegno nazionale dell’associazione Famiglie SMA Onlus, “Cellule staminali e SMA”, 21-23 June 2013, Roma, Italy
  105. Convegno “CELLULE STAMINALI: Un cammino tra speranza di cura, scienza e rispetto delle regole”, 11 June 2013, Roma, Italy
  106. Università e Comune di Trieste, Ciclo di incontri “Science & The City”, “Cellule staminali, tra mito e realtà”, 31 May 2013, Trieste, Italy
  107. Debra SudTirol, Meeting annuale, 6 April 2013, Dobbiaco (BZ), Italy
  108. UniStem, V edizione della Giornata della Scienza dedicata alle scuole superiori, 15 March 2013, Modena, Italy
  109. Democenter-Sipe, “Innovaday”, 30 November 2012, Mirandola (MO), Italy
  110. UniStem, IV edizione della Giornata della Scienza dedicata alle scuole superiori, 9 March 2012, Modena, Italy
  111. Incontro con i pazienti affetti da Epidermolisi Bollosa, 18 February 2012, Modena, Italy
  112. BIOTECH 2011, Sessione “Cell Therapies”, 6 October 2011, Milano, Italy
  113. UNISALUTE, Convegno “Le cellule staminali e il loro impiego attuale nella clinica”, 30 September 2011, Bologna, Italy
  114. UniStem, Giornata su “Cellule Staminali nella sperimentazione clinica”, 24 June 2011, Milano, Italy
  115. Debra SudTirol, Meeting annuale, 2 April 2011, Dobbiaco (BZ), Italy
  116. Accademia Nazionale di Scienze Lettere e Arti di Modena, “Cellule staminali: realtà e fantasia”, 5 March 2011, Modena, Italy
  117. Debra Italy, Meeting annuale, 11 December 2010, Roma, Italy
  118. Debra Italy, “un sorriso per Natale”, 1 December 2010, Roma, Italy
  119. UniStem, “Viaggio nel mondo delle cellule staminali tra presente e futuro: la comunicazione di una scoperta e l’attesa del malato”, Università degli Studi di Milano, 29 November 2010, Milano
  120. Debra Italy, “Torino per la ricerca”, 26 November 2010, Torino, Italy
  121. Gruppo Giovani Industriali di Modena, “Aperitivo con l’innovazione: medicina rigenerativa”, 27 September 2010, Modena, Italy
  122. CIAMI, Meeting Annuale Sindrome di Crigler-Najjar, 22-23 May 2010, Riccione (RN), Italy
  123. EURORDIS, III Giornata Internazionale delle Malattie Rare, 28 February 2010, Modena, Italy
  124. Cultura e vita, VI Ciclo “Storia della Medicina e antropologia medica”, 25 February 2010, Modena, Italy
  125. Maratona Telethon, 11 December 2009, RAI
  126. 1day2win Charity Marathon, 11 September 2009, Cesenatico, Italy
  127. Chiesi R&D Award, 7 April 2009, Parma, Prof. Graziella Pellegrini and Prof. Michele De Luca
  128. UniStem, 6ª Giornata di Studio sulle Cellule Staminali “Terapia genica e cellule staminali”, Milano, 30 January 2009
ARTICLES
  1. Il Foglio, Coronavirus e pensiero antiscientifico, due virus pericolosi per la nostra società, 28 March 2020
  2. Scienza in rete, AVIGAN e le terapie a furor di popolo, 28 March 2020 (Enrico Bucci, Gilberto Corbellini e Michele De Luca)
  3. Il Sole 24 Ore, Che fatica oggi fare lo scienziato, 24 February 2019 (Gilberto Corbellini e Michele De Luca)
  4. Il Sole 24 Ore, Editing genetico: Libertà di ricerca o anarchia?, 9 December 2018
  5. Il Sole 24 Ore, Cellule staminali: Un futuro di terapie avanzate, 24 April 2018
  6. Il Sole 24 Ore, Dignitas e pietas, valori dimenticati, 5 March 2017
  7. Il Sole 24 Ore, Diritti civili e libera ricerca, 23 October 2016
  8. Il Sole 24 Ore, Senza animali non si fa ricerca, 8 May 2016
  9. Il Sole 24 Ore, Morire con dignità, 27 December 2015
  10. Il Sole 24 Ore, Santi in Parlamento, 6 December 2015 (Gilberto Corbellini e Michele De Luca)
  11. Il Sole 24 Ore, Per un comitato al passo coi tempi, 24 May 2015 (Gilberto Corbellini e Michele De Luca)
  12. Il Sole 24 Ore, Perchè selezionare gli embrioni, 19 April 2015
  13. Il Sole 24 Ore, Stamina: la fine triste della partita?, 18 January 2015
  14. La Stampa, Al congresso dell’Associazione Coscioni cerchiamo studiosi non solo creativi, ma coraggiosi, 17 September 2014 (Marco Cappato, Gilberto Corbellini e Michele De Luca)
  15. Gazzetta di Modena, Il caso Stamina e la pseudomedicina, 4 September 2014
  16. Gazzetta di Reggio, Stamina e la medicina mediatica, 4 September 2014
  17. Il Sole 24 Ore, L’Europa, la biologia e l’identità dell’embrione, 20 July 2014 (Gilberto Corbellini e Michele De Luca)
  18. Il Sole 24 Ore, In vitro solo cellule, 13 July 2014 (Gilberto Corbellini e Michele De Luca)
  19. Il Sole 24 Ore, Uno standard per i giudici, 29 June 2014 (Gilberto Corbellini e Michele De Luca)
  20. Il Sole 24 Ore, Stamina, lo Stato si muova, 8 June 2014 (Elena Cattaneo, Gilberto Corbellini e Michele De Luca)
  21. La Stampa, Iene e sanità: vergognose falsità trash, 31 May 2014 (Elena Cattaneo, Gilberto Corbellini e Michele De Luca)
  22. Il Sole 24 Ore, Niente da sperimentare, 27 April 2014
  23. Scienza in rete, Stamina: quale etica sottende il decreto Balduzzi?, 25 March 2014
  24. Il Sole 24 Ore, Medicina populista, 2 February 2014
  25. Il Sole 24 Ore, Pericolo intruglio Stamina, 22 December 2013
  26. Il Sole 24 Ore, La verità sulle staminali, 1 December 2013
  27. Il Sole 24 Ore, Quanti miliardi spendereste per Stamina?, 11 August 2013
  28. Il Sole 24 Ore, Staminali, mercato della speranza (Paolo Bianco e Michele De Luca)
INTERVIEWS
  1. Skuola.net, “White Mirror”, a tu per tu con gli scienziati più importanti d’Italia: intervista a Michele De Luca, 22 November 2019
  2. RAI 1, Uno mattina in famiglia, 19 November 2019
  3. Radio 3 Scienza, 21 October 2019
  4. Italia 1, Le Iene, ospedali da sogno: come riacquistare la vista con le staminali, 15 October 2019
  5. Telecolor, Nuove terapie per i Bambini Farfalla, 29 May 2019
  6. RegmedNet, Curing the butterfly children: an interview with Michele De Luca, 25 February 2019
  7. ABC Australia, The Conversation Hour: Stem cell pioneers Doug Melton, Michele De Luca, and Caroline Gargett, 20 June 2020
  8. RAI 3, TGR, 22 May 2018
  9. RAI 3, Buongiorno Regione, 22 May 2018
  10. TRC, Nautilus: Una cellula ci salverà, 9 February 2018
  11. TRC, Il medico e il cittadino: le terapie con le cellule staminali, 20 November 2017
  12. RAI 3, Geo, Nuova pelle con le staminali a un “bimbo farfalla”, 15 November 2017
  13. Radio radicale, Il maratoneta, 11 November 2017
  14. RAI 1, Uno mattina in famiglia, Il fatto del giorno, 11 November 2017
  15. Radio Inblu, Tg e non solo, 8 November 2017
  16. RAI Radio1, Italy Sotto Inchiesta: “Scienza e venditori di fumo”, 27 April 2017
  17. Radio24, Smartcity: “Speciale uomo bionico: organi bio-artificiali”, 5 April 2017
  18. RAI3, Tutta Salute: “I grandi progressi della medicina rigenerativa”, 20 October 2016
  19. Scleroweb, Viaggio nelle cellule staminali: quarta puntata, 27 June 2016
  20. Scleroweb, Viaggio nelle cellule staminali: seconda puntata, 4 June 2016
  21. TRC, Detto tra noi, 16 May 2016
  22. Telemantova, Medicina in linea, 5 May 2016
  23. TvQui, In onda, 5 May 2016
  24. RAI 3, Elisir, 14 May 2015
  25. LaNiUslettER, “Cellule staminali epiteliali e sviluppo di terapie innovative ed avanzate”, 2 December 2014
  26. RAI 1, Superquark: “Come si fa: staminali tra scienza e pseudoscienza”, 28 August 2014
  27. RAI 3, Elisir: “Staminali che curano”, 20 May 2014
  28. TRC Modena, Detto tra noi: “La terapia genica per i Bambini Farfalla”, 14 January 2014
  29. Rai 3, Presa diretta, 13 January 2014
  30. RAI Radio1, Zappingduepuntozero, 12 September 2013
  31. Oggi scienza, Re-Post: “Cellule staminali, un caso ancora aperto”, 3 June 2013
  32. Rai news 24, 10 May 2013
  33. LaScienzaAttiva, “Le cellule staminali raccontate da Michele De Luca: rigenerazione epiteli”, 3 April 2013
  34. Radio 3 Scienza “Staminali della discordia”, 26 March 2013
  35. RAI Radio3, Radio3scienza: “Speranze staminali”, 14 March 2013
  36. eCancerTV, “History of stem cell use in the clinical setting”, 14 December 2012
  37. TSN (The Science Network), “Making Repairs: Stem Cells and the Pressures of Translational Medicine”, 31 October 2012
  38. RAI, Ippocrate: “Staminali: tra speranza e realtà, 14 October 2012
  39. Quotidiano.net, “Intervista Michele De Luca”, 3 July 2012
  40. Maratona Telethon, 11 December 2009, RAI, Roma, Italy
  41. Italy1, Le Iene: “Golia: cellule staminali”, 13 March 2009